Characterization Of Transcriptional Activators In The Fungal Circadian Clock by Gee, Kenneth
 
 
CHARACTERIZATION OF TRANSCRIPTIONAL ACTIVATORS IN THE 
FUNGAL CIRCADIAN CLOCK 
 
 
 
 
 
 
 
 
A Dissertation 
Presented to the Faculty of the Graduate School 
of Cornell University 
In Partial Fulfillment of the Requirements for the Degree of 
Doctor of Philosophy 
 
 
 
 
 
 
by 
Kenneth Orval Gee 
January 2014
 
 
 
 
 
 
 
 
 
 
 
 
© 2014 Kenneth Orval Gee
CHARACTERIZATION OF TRANSCRIPTIONAL ACTIVATORS IN THE 
FUNGAL CIRCADIAN CLOCK 
 
Kenneth Orval Gee, Ph. D. 
Cornell University 2014 
 
Circadian clocks are a common biological feature that allows organisms to 
anticipate changes in their environments by synchronizing their biological activity 
to the Earth’s day and night cycle.  These clocks are transcriptional/translational 
feedback loops, where transcriptional activators act as positive elements to 
promote the expression of negative elements, which in turn inhibit their own 
formation.  While significant progress has been made in elucidating the function 
of circadian clock proteins, relatively little is known about their interactions on the 
molecular level. 
To address this issue, I investigated the transcriptional activators White 
Collar (WC) I and II, which in the well characterized clock model N. crassa 
associate to form the White Collar Complex (WCC) and promote the expression 
of the negative clock element Frequency (FRQ).  Also studied were the related 
WC homologs from Phycomyces blakesleeanus, Trichoderma atroviride, and 
Cryptococcus neoformans. 
Bioinformatic analysis of these proteins was used to design protein 
 ii 
 
fragments based on variations in their domain architecture.  Once generated, 
expression and purification conditions were optimized allowing for the generation 
of soluble variants, for crystallization screening and biophysical characterization 
using small-angle X-ray scattering. 
Results from these studies indicate the presence of a PAS AB repeat in 
both N. crassa WC I and II.  Purification of the PAS domain containing proteins 
with and without the proteins C-terminal zinc fingers resulted in apparent dimers 
in size-exclusion chromatography (SEC) experiments.  Copurification of WC I 
and II proteins resulted in the formation of a tetrameric PAS mediated complex 
as shown by SDS-PAGE, SEC, light-scattering and small-angle X-ray scattering, 
suggesting the formation of a PAS mediated WCC containing four zinc fingers, 
which may facilitate the binding of multiple DNA sequences in the FRQ promoter 
region during transcription.
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CHAPTER 1 
GENERATION OF SOLUBLE FUNGAL CIRCADIAN TRANSCRIPTIONAL 
ACTIVATORS FOR BIOPHYSICAL CHARACTERIZATION 
 
1.1  Introduction 
1.1.1  Circadian Clocks  
Synchronization of biological activity to the diurnal light cycle is one of the 
most prevalent features in nature.  To facilitate this temporal organization, 
eukaryotic organisms have developed endogenous molecular 
transcriptional/translational feedback loops (TTFL), termed circadian clocks, 
which allow organisms to anticipate daily changes in their environment [1].  
Common features among all clocks are inputs, oscillators and outputs.  Inputs or 
environmental cues known as zeitgebers, which principally include food, light and 
to a lesser extent temperature, help to synchronize and entrain the clocks to the 
24 h cycle [2, 3].  Oscillators are composed of positive and negative elements 
that form biological feedback loops (Figure 1.1).  The positive clock elements are 
transcription factors that promote the expression of negative elements, which in 
turn inhibit their own activity.  In addition to the negative clock elements, are 
outputs termed clock controlled genes (ccgs), which serve important and diverse 
roles in the organism’s physiology [2]. 
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Figure 1.1  Positive and Negative Clock Element Interact to Form Biological 
Feedback Loops.  A common feature among circadian clocks is the presence of 
positive and negative clock elements that form transcriptional/translational feedback 
(TTFL) loops.  The positive elements, promote the expression of a variety of clock 
controlled genes including negative elements, which once expressed act to inhibit the 
action of the positive elements, suppressing their own transcription. 
 
1.1.2  Using Neurospora crassa as a Circadian Clock Model System 
To further our understanding of circadian clocks, we chose to focus on 
proteins derived from Neurospora crassa (N. crassa), which offers several 
advantages.  First, N. crassa has a long history of study and serves as one of the 
best characterized clock models [4].  This understanding has come from 
extensive use in genetic experimentation, such as the work done by Beadle & 
Tatum in development of the one gene/one enzyme hypothesis, for which they 
were awarded the Nobel Prize [5].  Additionally, the use of race tubes (clear 
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glass tubes filled with growth media) has allowed researchers to readily evaluate 
the effects of genetic mutations on the clock by monitoring alterations in the 
organisms circadian mycelial (vegetative) and conidial (aerial hyphae) growth, 
which appear respectively as alternating dark and light bands [6].  Finally, while 
the individual proteins vary in the fungal, plant and animal models, the basic 
TTFL motif remains conserved among the different clock models.  As seen in 
Figure 1.1.1, the positive elements in N. crassa, White Collar I [7] and II [8, 9], 
are reflected in the Drosophila melanogaster (D. melanogaster) transcription 
factors CLOCK and Cycle as well as CLOCK and BMAL1 in the Mus musculus 
(M. musculus) model [10].  Also retained is the presence of negative elements, 
which are Frequency in N. crassa, Period and Timeless in D. melanogaster and 
Period 1, 2, 3 and Cryptochrome in the M. musculus model [4]. 
1.1.2.1  N. crassa Circadian Clock Proteins and Their Interactions 
As mentioned previously, the N. crassa positive clock elements are the 
White Collar I and II (WC I and II) PAS domain containing transcription factors.  
PAS domains are named for the first three proteins in which they were observed 
(Period, Aryl hydrocarbon receptor nuclear translocator and Singleminded) and 
serve a wide range of functions based on their biological context [11, 12].  The 
domains are composed of an α/β-fold (Aβ, Bβ, Cα, Dα, Eα, Fα, Gβ, Hβ and Iβ) 
with the α-helices flanking the β-sheet [11], as shown in a ribbon model of the 
crystal structure of Azotobacter vinelandii NifL (PDB: 2GJ3) (Figure 1.1.2 A) and 
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Figure 1.1.1  Positive and Negative Elements are Retained in Different Clock 
Models.  Comparison of positive and negative elements is shown respectively from N. 
crassa (White Collar I, II and Frequency), D.melanogaster (CLOCK, Cycle and Period, 
Timeless) and the M. musculus model (CLOCK, BMAL1 and Period 1, 2, 3, 
Cryptochrome 1, 2).  The presence of these proteins in different models indicates a 
conservation of the basic clock motif. 
 
in a diagram of the canonical PAS fold [13] (Figure 1.1.2 B). 
In N. crassa WC I and II, the PAS domains facilitate heterodimerization of 
the transcription factors starting late at night to form the White Collar Complex 
(WCC) [14, 15].  Additionally, they serve as the organisms photoreceptor, which 
helps in synchronize the clock with the diurnal cycle through the use of a flavin-
binding subclass of the PAS domain, known as the Light, Oxygen and Voltage 
(LOV domain) in WCI [16, 17]. 
Following its formation the WCC binds four cis-acting pseudo-palindromic 
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Figure 1.1.2  The Canonical PAS Domain is an α/β-fold.  The PAS fold is composed 
of a conserved mixed α/β-fold, with α-helices flanking a β-sheet as seen in A) the ribbon 
model of Azotobacter vinelandii NifL (PDB: 2GJ3) and B) a diagram of the canonical 
PAS fold. 
 
sequences termed light response elements in the frequency promoter region 
(Clock-box) [18], which upon light exposure at dawn undergoes a significant 
increase in activity resulting in expression of the negative element Frequency 
(FRQ) [18] (Figure 1.1.3).  Once expressed, FRQ dimerizes though an N-terminal 
coiled coil domain [19] and associates with Frequency interacting RNA helicase 
(FRH) [20] to form the FFC [21].  The FFC then enters the nucleus where it 
promotes phophorylation of the WCC by casein kinase 1a (CKIa) and CK2, which 
decreases affinity of the WCC for the promoter, resulting in its inactivation [20-
23].  Throughout the day, FRQ is progressively phosphorylated by CKIa and CK2  
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Figure 1.1.3  The N. crassa Circadian Clock is a Transcriptional/Translational 
Feedback Loop.  The transcription factors White Collar I and II (WC I and II) associate 
to form a transcriptional activation complex (WCC), which in addition to functioning as 
the organisms light sensor, interacts with Vivid (VVD) to mediate light attunement.  At 
dawn the WCC undergoes a significant increase in activity, promoting expression of 
Frequency (FRQ), which dimerizes and associates with a FRQ-interacting RNA helicase 
(FRH) to form the FFC.  Once formed, FCC mediates casein kinase Ia and 2 (CKIa and 
CK2) phosphorylation of the WCC, resulting in its inactivation.  Throughout the day FRQ 
is phoshorylated by CK1a and CK2, which triggers its degradation by FWD1.  This 
decrease in FRQ mediated phoshorylation, coupled with PPA2a dephosphorylation 
restores WCC activity.  Once bound, the active WCC is triggered for degradation by the 
(SCF) FWD1 Ubiquitin-ligase complex (FWD1), allowing the cycle to repeat.  In addition 
to FRQs role at a negative clock element, is its role in stabilizing WC I in the cytoplasm 
prior to formation of the WCC. 
 
[21, 24] and triggered for degradation by the Ubiquitin proteosome pathway [21, 
25].  As FRQ levels decrease, the corresponding FRQ promoted WCC 
phophorylation also decreases and is reversed by PP2a [25].  This in turn 
reactivates the WCC, allowing for its binding to the promoter region and 
expression of FRQ, with subsequent clearance from the nucleus, as once bound 
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active WCC is quickly degraded allowing the cycle to restart [21, 26-28].  In 
addition to the core clock interactions, FRQ also participates in a positive 
feedback loop by mediating CKIa phophorylation of WC I in the cytoplasm 
following its expression (Figure 1.1.3).  This serves to stabilize and inactivate the 
protein until it associates with WC II forming the WCC and moves into the 
nucleus where it is dephosphorylated by PPA2a [23]. 
Also observed is the interaction between Vivid (VVD) [29] and the WCC.  
In this case, VVD which contains a LOV domain, is thought to facilitate clock light 
attunement through interactions with the WCC [30] (Figure 1.1.3). 
1.1.3  Approach Taken to Studying Circadian Clock Proteins 
While significant progress has been made in elucidating the function [31, 
32] and structures of several core circadian clock components such as the 
negative elements N. crassa Vivid [33], Drosophila melanogaster Cryptochrome 
[34] and Period [35] as well as the Mus musculus CLOCK/BMAL1 transcriptional 
activator complex [10], relatively little structural information is available to help 
inform the design of novel WC I and II variants (fragments of the full-length 
protein).  This problem is further complicated by low sequence identity among 
PAS domains even though the α/β-fold is well conserved [36]. 
To address this problem, bioinformatic analysis of fungal circadian clock 
transcriptional activator variants from N. crassa WC I [37], WC II [8], as well as 
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the related Phycomyces blakesleeanus MADB [38, 39], Trichoderma atroviride 
BLR-2 [40] and Cryptococcus neoformans WC I and II [31, 41] was performed.  
From this analysis, variants based on the proteins domain architecture were 
generated using a bacterial expression system and purified for biophysical 
characterization. 
 Results from these efforts identified soluble PAS domain containing 
variants based on the inclusion of conserved residues C-terminal to the identified 
PAS domains, as well as variants containing the C-terminal zinc finger, allowing 
for crystallization screening and characterization using small-angle X-ray 
scattering as discussed in Chapter 2. 
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1.2  Materials and Methods 
1.2.1  Generating Fungal Circadian Transcriptional Activators 
 Circadian clock transcriptional activators from N. crassa, P. blakesleeanus, 
T. atroviride and C. neoformans were expressed and purified for solution and 
structural studies.  To facilitate these studies, soluble protein variants were 
generated from the evaluation of sequence homology to related proteins, 
secondary structural predictions and sequence comparison to solved structures 
using online bioinformatic web servers.  In each case, analysis of the submitted 
sequence was performed using default parameters.  
Comparison of the homologs primary sequence to related proteins and 
structures deposited in Protein Data Bank (PDB) [42] identified as having 
sequence homology, were facilitated using the National Center for Biotechnology 
Information (NCBI) [43] Basic Local Alignment Search Tool (BLAST) [44, 45].  
Additional proteins for sequence comparison were identified with the Pfam 
domain database (Version 27.0) [46] and NCBI Conserved Domain Database 
(CDD) (Version 3.10) [47]. 
Secondary structural predictions were generated using Jpred (Version 3) 
[48] and XtalPred [49-52] web servers. 
Primary sequence alignments were performed by GenomeNet using the 
ClustalW algorithm [53] and presented with ESPript [54]. 
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1.2.2  Cloning Fungal Circadian Clock Proteins 
N. crassa White Collar I and II (WC I and II), P. blakesleeanus Mitotic 
Arrest Deficient B (MADB), T. atroviride Blue-Light Regulator-2 (BLR-2) and C. 
neoformans WC I and II proteins were cloned into pet28 with an N-terminal 6xHis 
tag (Novagen) and overexpressed with Escherichia coli (E. coli) BL21 (DE3) cells 
(Invitrogen) using standard protocols. 
DNA oligomers (Integrated DNA Technologies) and restriction enzymes 
(New England Biolabs) NdeI/XhoI were used to clone N. crassa, P. 
blakesleeanus and T. atroviride, whereas C. neoformans was cloned with 
NdeI/NotI.  Verification of cloned DNA sequences was performed at the Cornell 
University Life Sciences Core Laboratories Center. 
cDNA used in this study was generously provided by the following 
researchers: N. crassa White Collar I and II, by Jay C. Dunlap, Ph.D., Dartmouth 
College, Dartmouth Medical School, Hanover, NH.  P. blakesleeanus MADB by 
Luis M. Corrochano, Ph.D., Departamento de Genética, Universidad de Sevilla, 
Seville, Spain.  T. atroviride BLR-2 by Alfredo Herrera-Estrella, Ph.D., 
Laboratorio Nacional de Genómica para la Biodiversidad, Centro de 
Investigación y de Estudios Avanzados del IPN Sede Irapuato, Guanajuato, 
Mexico.  C. neoformans White Collar I and II by Alexander Idnurm, Ph.D., 
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University of Missouri-Kansas City, Division of Cell Biology and Biophysics, 
School of Biological Sciences, Kansas City, MO. 
1.2.2.1  Cloning N. crassa WC I 
N. crassa WC I, amino acid residues 705-918 (705-918) and (705-1000) 
constructs were cloned previously into pet28 with an N-terminal 6xHis tag 
(Novagen) using standard PCR protocols, and provided for overexpression in E. 
coli BL21 (DE3) cells (Invitrogen). 
1.2.2.2  Cloning N. crassa WC II 
Sense (forward) and antisense (reverse) primers used to clone N. crassa 
WC II proteins are shown with the N-terminal or C-terminal residue followed by 
the needed sequence: 
Sense: 154: 5'-GCCGAC CATATG AGC ACC CTG ACC GAA TTC ACC-
3', 174: 5'-GCCGAC CATATG CAG GAC TGG GAA CAC ATT CTG-3', 179: 5'-
GCCGAC CATATG ATT CTG GAT GCC AAC GGA CGG-3'. 
Antisense: 285: 5'-GCCGAC CTCGAG TCA GTA GGG TCG AGC CAT 
CAT GAA-3', 312: 5'-GCCGAC CTCGAG TCA CTC GGC AAT CCT GCG CTT 
CAG-3', 323: 5'-GCCGAC CTCGAG TCA CTC TTC CTG CTC CTC CTG CTC-
3', 445: 5'-GCCGAC CTCGAG TCA AAT CGC GAT TCC CGC ATC ACC-3', 449: 
5'-GCCGAC CTCGAG TCA TCG GTC TAG GGG AAT CGC GAT-3', 453: 5'-
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GCCGAC CTCGAG TCA CGT CCG GGG ATC TCG GTC TAG-3', 455: 5'-
GCCGAC CTCGAG TCA CTC TCC CGT CCG GGG ATC TCG-3', 500: 5'-
GCCGAC CTCGAG TCA TTT CTT TGC CCA GCG AAG ACC-3'. 
Combinations of these primers were used to generate the following N. 
crassa WC II proteins from the full-length protein, amino acid residues: 154-285 
(154-285), (154-312), (154-323), (174-445), (174-449), (174-453), (174-455) and 
(179-500). 
1.2.2.3  Cloning P. blakesleeanus MADB 
Sense and antisense primers used to clone P. blakesleeanus MADB 
proteins are shown with the N-terminal or C-terminal residue followed by the 
needed sequence: 
Sense: 1: 5'-GCCGAC CATATG ATG GAA TCA GCT CGT CAA CCT-3', 
27: 5'-GCCGAC CATATG CCC CCA ACC ACA GTC CAG GCT-3'. 
Antisense: 181: 3'-GCCGAC CTCGAG TCA ATT CTG CTGCTG TTG CTT 
CTG-5', 286: 3'-GCCGAC CTCGAG TCA GAC TGT TAC TCT CTC TAT ACT-5', 
289: 3'-GCCGAC CTCGAG TCA TTC ATC GTG GAC TGT TAC TCT-5', 293: 3'-
GCCGAC CTCGAG TCA AGT TTC TTC ATC TTC ATC GTG-5', 297: 3'-
GCCGAC CTCGAG TCA CTG TTG CTC GTT AGT TTC TTC-5', 300: 3'-
GCCGAC CTCGAG TCA GAC TCT CTT CTG TTG CTC GTT-5', 346: 3'-
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GCCGAC CTCGAG TCA GCT TGT CTT TGC CCA ACG TAA-5', 354: 3'-
GCCGAC CTCGAG TCA TAT GTC TGA CCC ATC TGG TCT-5'. 
1.2.2.4  Cloning T. atroviride BLR-2 
Sense and antisense primers used to clone T. atroviride BLR-2 proteins 
are shown with the N-terminal or C-terminal residue followed by the needed 
sequence: 
Sense: 1: 5'-GCCGAC CATATG ATG TCC CAC GGG CCG CCT CCA-3', 
133: 5'-GCCGAC CATATG CTG ACC GAG TTC ACC AAG CGC-3'. 
Antisense: 297: 3-GCCGAC CTCGAG TCA TTC TGC CTC TTC TTC TCT 
CCG-5', 318: 3'-GCCGAC CTCGAG TCA GGA TGG AGT GAT GTC TGA CCG-
5', 408: 3'-GCCGAC CTCGAG TCA AAT AGC AAT TCC GGC ATC GCC-5', 411: 
3'-GCCGAC CTCGAG TCA CCG ATC CAT GGG AAT AGC AAT-5', 415: 3'-
GCCGAC CTCGAG TCA TGA TCT ATT CTC CCG ATC CAT-5', 417: 3'-
GCCGAC CTCGAG TCA CTC TCC TGA TCT ATT CTC CCG-5', 467: 3'-
GCCGAC CTCGAG TCA GTT GCG CTT CTT TTC CTT CTT-5', 484: 3'-
GCCGAC CTCGAG TTA GCC TGC AGC TGG AGT TGC CGT-5'. 
Combinations of these primers were used to generate the following T. 
atroviride BLR-2 proteins from the full-length protein: (1-484), (133-297), (133-
318), (133-408), (133-411), (133-415), (133-417) and (133-467). 
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Combinations of these primers were used to generate the following P. 
blakesleeanus MADB proteins from the full-length protein: (1-354), (27-181), (27-
286), (27-289), (27-293), (27-297), (27-300) and (27-346). 
1.2.2.5  Cloning C. neoformans WC I 
Sense and antisense primers used to clone C. neoformans WC I proteins 
are shown with the N-terminal or C-terminal residue followed by the needed 
sequence: 
Sense: 431: 5'-GCCGAC CAT ATG CCC CAT CAA ATT GAC TTC TCC-
3', 456: 5'-GCCGAC CAT ATG TTG TCA TCT ACG ACT TCG TAT-3', 474: 5'-
GCCGAC CAT ATG CAC CCA CTA CTA TCT CCC GCC-3'. 
Antisense: 637: 3'-GCCGAC GC GGC CGC TCA AAC CAA GTC AAT 
TTG GAA GCC-5'. 
Combinations of these primers were used to generate the following C. 
neoformans WC I proteins from the full-length protein: (431-637), (456-637) and 
(474-637). 
1.2.2.6  Cloning C. neoformans WC II 
Sense and antisense primers used to clone C. neoformans WC II proteins 
are shown with the N-terminal or C-terminal residue followed by the needed 
sequence. 
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Sense: 1: 5'-GCCGAC CATATG ATG TCC CTC CTC GCC GAG TCT-3', 
26: 5'-GCCGAC CATATG AAT GGT GCC GCC GAG TTC CTG-3'. 
Antisense: 250: 3'-GCCGAC GCGGCCGC TCA TGA TTT TTG ATC TTC 
ATT ACT-5', 276: 3'-GCCGAC GCGGCCGC TCA TCC TAC TTC TTCTTC CAG 
TTC-5', 282: 3'-GCCGAC GCGGCCGC TCA AGA ATC TTC AAC TGT CAT 
TCC-5', 289: 3'-GCCGAC GCGGCCGC TCA TGC AGA CTG ATT GTT GTT 
TAT-5', 301: 3'-GCCGAC GCGGCCGC TCA TGG AGT ATC TGT CGA TGA 
ATG-5', 306: 3'-GCCGAC GCGGCCGC TCA CTT GTC TCC ACC CGG TGG 
AGT-5', 311: 3'-GCCGAC GCGGCCGC TCA AGC TTT GTT CTT ATT CTT 
GTC-5', 315: 3'-GCCGAC GCGGCCGC TCA ATT CTT GTC AGC TTT GTT CTT 
-5', 317: 3'-GCCGAC GCGGCCGC TCA CGT TTT CGG ATT CTT GTC AGC-5', 
320: 3'-GCCGAC GCGGCCGC TCA TTG AGT GTT CGT TTT CGG ATT-5', 323: 
3'-GCCGAC GCGGCCGC TCA AGC AGA AAC TTG AGT GTT CGT-5', 327: 3'-
GCCGAC GCGGCCGC TCA CTT GTC CCC CGA AGC AGA AAC-5', 329: 3'-
GCCGAC GCGGCCGC TCA TCT CTT GTG CCC CGA AGC AGA-5', 331: 3'-
GCCGAC GCGGCCGC TCA AGA CTT TTG TCT CTT GTG CCC-5', 337: 3'-
GCCGAC GCGGCCGC TCA CGT TTT CGG GGG GCG TCC AGC-5', 340: 3'-
GCCGAC GCGGCCGC TCA TGA AGC TCC TGC CGG GCC-5', 378: 3'-
GCCGAC GCGGCCGC TCA TGC CCA TCT TAG TCC ACA GGC-5', 380: 3'-
GCCGAC GCGGCCGC TCA TCG TTT TGC CCA TCT TAG TCC-5', 383: 3'- 
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GCCGAC GCGGCCGC TCA AGT TGA ATT TCG TTT TGC CCA-5', 392: 3'-
GCCGAC GCGGCCGC TCA AGA TTG CTT ATC TTT TTT GGG-5'. 
Combinations of these primers were used to generate the following C. 
neoformans WC II proteins from the full-length protein: (1-392), (26-250), (26-
276), (26-282), (26-289), (26-301), (26-306), (26-311), (26-315), (26-317), (26-
320), (26-323), (26-329), (26-340), (26-378), (26-380) and (26-383). 
1.2.3  Expressing Fungal Circadian Clock Transcriptional Activators  
Unless otherwise stated, expressed proteins were grown at 37 °C in 
Lysogeny broth [55] medium until the OD@600 nm was 0.7 to 1.0 while shaking 
at 180 to 200 rpm.  In each case, the temperature was reduced to 17 °C and 
allowed to equilibrate for 45 min to 1 h.  The cells were then induced with 100 to 
200 µM Isopropyl β-D-1-thiogalactopyranoside (IPTG), expressed for 16 to 20 h 
and harvested with centrifugation at 4 °C for 10 min at 8,000 rpm.  Following 
harvest, the proteins were flash frozen in liquid nitrogen and stored at -80 °C. 
1.2.4  Purifying Expressed Proteins 
 To purify expressed proteins, approximately 25 g of frozen cellular material 
(cell pellets) were first resuspended and mixed on ice with lysis buffer containing 
300 mM NaCl, 50 mM Tris buffer (TRIS) pH 7.5, 10 mM imidazole, 10% v/v 
glycerol, 1 to 2mM dithiothreitol (DTT) or 2 mM Tris(2-carboxyethyl)phosphine 
(TCEP) using an approximate ratio of 4 to 10 mL lysis buffer for each gram of 
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cellular pellet up to a maximum resuspension volume of 200 mL.  The 
suspension was then lysed on ice with mixing between four alternating 2 s on/2 s 
off sonication cycles each lasting 2 min. 
Following sonication, the proteins were centrifuged for approximately 45 
min to 1 h at 22,000 rpm and the supernatant was first collected, then applied to 
an Ni:NTA Sepharose [56] gravity flow column with a 2 to 3 mL bed volume 
equilibrated with lysis buffer for immobilized metal affinity chromatography 
(IMAC) purification.  Bound protein was washed with 25 column volumes [57] of 
lysis buffer, followed by 25 cv of a wash buffer containing 300 mM NaCl, 50 mM 
Tris pH 7.5, 20 mM imidazole, 10% v/v glycerol, 1 to 2 mM DTT or 2 mM TCEP.  
Bound protein was eluted from the column with elution buffer containing 300 mM 
NaCl, 50 mM Tris pH 7.5, 300 mM imidazole, 10% v/v glycerol, 1 to 2 mM DTT or 
TCEP (reductant composition was maintained in purifications) in 1.5 to 2 mL 
aliquots.  Fractions containing protein as determined by Bradford assay [58], 
were pooled and loaded onto an ÄKTA fast protein liquid chromatography 
instrument coupled to a HiLoad 26/60 Superdex 200 or when specifically noted, a 
Superdex 75 prep grade gel filtration column (GE Healthcare) equilibrated with 
150 mM NaCl, 50 mM Tris pH 7.5, 10% v/v glycerol, 1 to 5 mM DTT and/or 2-5 
mM TCEP and  fractionated in 6 mL aliquots using a 2.5 mL/min flow rate at 4 °C 
for X-ray crystallographic and small-angle X-ray scattering studies. 
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Fractional elutions were assessed with a Coomassie Brilliant Blue R-250 
(Bio-Rad) stained 10% or 4-12% Bis-TRIS SDS-PAGE gel with a 1x dilution of 
MES running buffer (20x stock: 50 mM MES, 50 mM Tris Base, 0.1% SDS, 1 mM 
EDTA, pH 7.3) or 1x dilution of MOPS running buffer (20x stock: 50 mM MOPS, 
50 mM Tris Base, 0.1% SDS, 1 mM EDTA, pH 7.7) (Invitrogen). 
1.2.5  Concentrating Expressed Proteins 
Fractions collected from size-exclusion chromatography (SEC) [59] 
purifications were pooled and stored at 4 °C for concentration with 10 kDa 
Amicon Ultra-15 Centrifugal Filter Units (Millipore).  Prior to use, concentrator 
membranes were prepared by passing 15 to 17 mL of the gel filtration buffer 
(GFB) through the membrane to remove possible contaminates from the 
manufacturing process, such as residual glycerol on the membrane.  Once 
equilibrated, the protein was concentrated with the filter units by centrifugation at 
3,000 rpm with mixing every 10 to 20 min until the total volume was reduced to 
15 to 17 mL.  At this point, the centrifugation rate was reduced to approximately 
2,000 rpm with mixing every 10 min until the desired concentration was obtained, 
as determined by Bradford assay. 
Once concentrated, proteins were stored at 4 °C for immediate use or for 
overnight cleavage of the 6xHis tag, with varying amounts of Human α-Thrombin 
(Haematologic Technologies), as monitored by SDS-PAGE gel analysis.  
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Proteins not screened immediately were aliquoted, flash frozen in liquid nitrogen 
and stored at -80 °C. 
SEC elution profiles and SDS-PAGE gels for each of the studied variants 
are presented with the N-terminal 6xHis tag. 
1.2.6  Crystallization Screening of Expressed Proteins 
 Expressed proteins were screened manually and robotically (ArtRobbins: 
Phoenix) in the Weill Institute for Cell and Molecular Biology at Cornell University 
with custom conditions and commercially available sparse matrix screens: 
Crystal Screen 1 and 2, PEG/Ion Screen 1 and 2, SaltRx 1 and 2, MembFac, 
Crystal Screen Lite (Hampton Research) Wizard Classic 1, 2, 3, 4 (Emerald 
BioSystems), NeXtal Tubes JCSG Core Suite I, II (Qiagen) in hanging and sitting 
drops. 
1.2.7  DNA Oligomers for N. crassa Crystallization Screening 
Sense and antisense primers used to screen N. crassa WC II (179-500) 
are shown with the N-terminal or C-terminal residue followed by the needed 
sequence: 
Sense: 5'- GATCCGCTCGATC-3’, 
Antisense: 3’-CTAGGCGAGCTAG-5’. 
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 DNA annealing was performed following a standard procedure as 
described on manufactures website (Idtdna.com). 
1.2.8  Supplemental Data for Studied Clock Proteins 
Experimental details for transcriptional activators and related clock proteins 
not discussed in Chapter 1 are provided in Appendix A.  
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1.3 Results 
1.3.1  N. crassa WC Expression Screening  
To date, efforts to express in E. coli soluble full-length N. crassa WC I and 
II proteins in quantities and purity needed for structural studies have proven 
unsuccessful in all conditions tested.  Previous efforts to address this problem 
utilized an expression screen of White Collar proteins N-terminally fused to green 
fluorescent protein (GFP) based on PCR cloning of WC I and WC II truncation 
constructs with random primers.  Production of fluorescent GFP acted as a 
folding reporter for the library of fusion proteins [60].  Results from these efforts 
identified soluble N. crassa WC II variants containing the Per-ARNT-Sim (PAS) 
[11, 61] and zinc finger domains [62]. 
Identification of these regions was facilitated with sequencing performed at 
Cornell University Life Sciences Core Laboratories Center (data not shown).  
From this work, N. crassa WC II (179-500) was selected for further analysis. 
1.3.2  Initial Purification of N. crassa WC II (179-500) 
 N. crassa WC II (179-500) was expressed by growing E. coli at 37 °C in LB 
medium while shaking at 200 rpm until the OD@600 nm was approximately 1.1.  
The cells were then induced with 500 µM IPTG, expressed for 3.5 h at 37 °C, 
centrifuged for 10 min at 4 °C and 8,000 rpm, harvested and flash frozen in liquid 
nitrogen. 
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To purify the protein, 25 g of frozen cell pellets were first resuspended on 
ice with lysis buffer containing 500 mM NaCl, 25 mM HEPES buffer pH 7.5, 5 
mM imidazole, using an approximate ratio of 4 mL lysis buffer for each gram of 
cellular pellet.  The suspension was then lysed on ice with mixing between three 
alternating 2 s on/2 s off sonication cycles lasting 2 min each. 
Following sonication the protein was centrifuged for 1 h at 4 °C and 22,000 
rpm.  The supernatant was then collected and applied to an Ni:NTA Sepharose 
gravity flow column with a 2 mL bed volume equilibrated with lysis buffer for 
immobilized metal affinity chromatography (IMAC) purification at room 
temperature (RT).  Bound protein was washed with 5 cv of lysis buffer, followed 
by 5 cv of a wash buffer containing 500 mM NaCl, 25mM HEPES pH 7.5, 20 mM 
imidazole.  Protein was eluted from the column with elution buffer containing 500 
mM NaCl, 25mM HEPES pH 7.5 and 200 mM imidazole in 1.8 mL aliquots.  
Eluted fractions containing protein, as determined with the Bradford assay, were 
loaded onto a HiLoad 26/60 Superdex 200 prep grade gel filtration column 
equilibrated with 150 mM NaCl, 50 mM Tris pH 7.5 and eluted in 6 mL aliquots at 
2.5 mL/min. 
SDS-PAGE gel analysis of elution fractions from IMAC purification show a 
38 kDa molecular weight band consistent with the predicted molecular weight for 
a N. crassa WC II (179-500) 6xHis tag labeled monomer (Figure 1.3.1). 
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Figure 1.3.1  IMAC Purification of N. crassa WC II (179-500) Shows Expression of 
Soluble Protein.  SDS-PAGE gel analysis of IMAC elution fractions shows a band 
consistent with the proteins theoretical 38 kDa molecular weight. 
 
 The SEC profile for N. crassa WC II (179-500) expressed at 37 °C 
indicated low absorbance peaks eluting at 192 and 220 mL, which when 
compared to known standards, were suggestive of a dimeric and monomeric 
species with apparent molecular weights of 90 and 38 kDa respectively (Figure 
1.3.1.1). 
This estimated molecular weight, based on elution volume, is larger than 
the calculated 76 kDa theoretical molecular weight for an expected 6xHis tag 
labeled WC II (179-500) dimer.  Additionally an elution peak was also observed 
eluting near the void volume (120 mL) with an apparent molecular weight of 
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Figure 1.3.1.1  SEC Purification of N. crassa WC II (179-500) using Initial 
Conditions Shows Low Levels of Soluble Protein.  The SEC profile of IMAC elution 
fractions shows peaks with low absorbance values at 192 and 220 mL.  From 
comparison with elution values to known standards, these peaks indicate an apparent 
90 kDa species, suggestive of a WC II (179-500) dimer (bracketed with red bars) and 38 
kDa monomer.  Also observed is a peak eluting near the void volume which is indicative 
of high molecular weight soluble aggregates. 
 
approximately 900 kDa, suggestive of soluble aggregates. 
1.3.2.1  N. crassa WC II (179-500) Small-scale Expression Test 
 In an effort to increase expression of soluble protein, a small-scale 
expression test was performed to determine the effect of temperature on protein 
solubility.  To facilitate this, protein was expressed by growing E. coli at 37 °C in 
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100 mL LB medium until the OD@600 nm was approximately 1.0 while shaking 
at 200 rpm.  The culture was then divided and one aliquot was induced with 500 
µM IPTG.  Cultures with and without induction were grown at RT and 37 °C with 
1 mL sampling at 3 and 5 h time points.  Samples were centrifuged at 4 °C for 10 
min at 13,000 rpm, harvested and flash frozen in liquid nitrogen for later analysis. 
 To evaluate protein expression, cell pellets were chemically lysed using 
BugBuster Protein Extraction Reagent (Millipore), incubated for 20 min at RT with 
rocking and then centrifuged at 4 °C for 10 min at 13,000 rpm.  15 μL of the 
supernatant and 1 μL pellet resuspended in 300 μL water was then loaded on a 
10% SDS-PAGE gel with MOPS running buffer. 
 Results from the small-scale expression testing (Figure 1.3.1.2) showed an 
increase in soluble protein when the induction temperature was reduced from 37 
°C to RT.  From this result, protein handling conditions were systematically varied 
in an attempt to improve protein solubility and purity. 
1.3.2.2  Improved N. crassa WC II (179-500) Solubility 
Systematic variation of N. crassa WC II (179-500) expression and 
purification conditions was performed to improve quantity and purity of expressed 
protein for crystallization screening.  Effects on soluble protein production and 
stability were evaluated by observing changes in the SEC elution profile, banding 
pattern on SDS-PAGE gels and total protein obtained after concentration, as 
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Figure 1.3.1.2  Small-scale Expression of N. crassa WC II (179-500) Indicates a 
Larger Fraction of Soluble Protein at Reduced Induction Temperatures.  SDS-
PAGE gel analysis of protein obtained from soluble and insoluble fraction at 3 and 5 h 
time points show a decrease in total protein, however, a relative increase in soluble to 
insoluble protein is observed when the induction temperature is reduced from 37 °C to 
room temperature. 
 
quantified by the Bradford Assay. 
Analysis of the SEC profile focused on absorbance intensity, shape and 
resolution for each of the elution peaks.  SDS-PAGE gel analysis of IMAC and 
SEC elution fractions were evaluated for protein loss in purification steps as well 
as for target enrichment relative to protein fragmentation (low molecular weight 
bands) and irreversible aggregation (high molecular weight bands).  Total protein 
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obtained from preparation of each cellular pellet was quantified using the 
Bradford assay.  Conditions varied in expression steps were a reduction in the 
IPTG concentration from 500 μM to 100-200 μM, a decrease in induction 
temperature from 37 °C to RT followed by a 1 h hold time, which allowed cell 
cultures to equilibrate at RT prior to induction.  Changes in purification steps 
included increasing sonication from three to four 2 min rounds (2 s on/2 sec off), 
increasing the resuspension volume to 5 mL lysis buffer for each gram of cell 
pellet and increasing imidazole concentration in the lysis buffer to 10 mM.  
Additionally, 10% glycerol and reductants (1-2 DTT mM or TCEP) were added as 
well as maintaining protein at 4 °C after thawing cellular pellets. 
Results from optimization of protein handling conditions for N. crassa WC 
II (179-500) showed an increase in absorbance for the primary SEC elution peak 
(Figure 1.3.1.3).  However as seen in the inserted SDS-PAGE gel, protein 
concentrated to 13 mg/mL displayed significant low and high molecular weight 
banding, indicative of protein fragmentation and formation of irreversible soluble 
aggregates even after heating for 10 min at 95 °C. 
Densitometric analysis of the SDS-PAGE profile of concentrated WC II 
(179-500) with Syngene GeneTools indicated the 38 kDa band composed 47% of 
the total protein, well below the purity ideally needed for X-ray crystallization 
studies [63]. 
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Figure 1.3.1.3  An Increase in Soluble N. crassa WC II (179-500) was Obtained 
From Variation in Expression and Purification Conditions.  The SEC elution profile 
shows a defined strong absorbance peak eluting at 197 mL, suggestive of a species 
with an apparent molecular weight of 76kDa, close to the theoretical 78 kDa molecular 
weight expected for a dimer.  SDS-PAGE analysis of SEC elutions and protein 
concentrated to 13 mg/mL shows protein corresponding to the 38 kDa theoretical 
molecular weight as well as low and high molecular weight bands consistent with 
fragmentation and irreversible aggregation.  Red bars on the SEC elution profile denote 
fractions collected for concentration. 
 
1.3.2.3  Crystallization Screening of N. crassa WC II (179-500) 
Efforts to crystallize N. crassa WC II (179-500) included manual and 
robotic screening of the protein at a variety of concentrations using custom  
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conditions and commercially available sparse matrix screens.  All screens were 
checked daily for 1 week, then weekly for 1 month and once per month (for 
several months). 
For manual screening, the hanging drop method was used with Crystal 
Screen 1 and 2, PEG/Ion Screen 1 and 2, SaltRx 1 and 2, MembFac, Crystal 
Screen Lite (Hampton Research).  Additional screening was performed with 
Wizard Classic 1, 2, 3, 4 (Emerald BioSystems).  Drops were set up with protein 
ranging from 0.5 mg/mL to 14 mg/mL in varying ratios of protein:well conditions 
at 4, 17 °C and RT.  Manual screening of custom conditions also included grid 
screens based on formulations found in the commercial screens with and without 
the addition of DTT and TCEP in concentration ranging from 1 to 5 mM in 
hanging and sitting drops, with 2 to 4 and 8 µL total drop volume respectively. 
Screening was also conducted with rationally designed DNA oligomers 
based on imperfect GATA (GATN) type binding sites indentified with 
electrophoretic mobility shift assays [18].  Sense and antisense primers were 
mixed in equimolar ratios in 150 mM NaCl, 50 mM Tris buffer pH 7.5, placed in a 
1 L beaker containing water, heated to 95 °C and allowed to cool gradually to RT.  
Once annealed, DNA was mixed with the protein in ratios ranging from 1:1 to 4:1 
(DNA:protein for 30 min on ice prior to setting up crystal screens.   
Robotic screening was performed with protein concentrated to 5 and 7 
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mg/mL at RT using Crystal Screen 1 and 2, PEG/Ion Screen 1 and 2, MembFac 
and Crystal Screen Lite (Hampton Research).  Additional screening was 
performed with Wizard Classic 1, 2, 3, 4 (Emerald BioSystems) and NeXtal 
Tubes JCSG Core Suite I, II (Qiagen). 
N. crassa WC II (179-500) concentrated to 14 mg/mL was also screened 
with Vivid (VVD) [64] concentrated to 18 mg/mL.  Prior to screening, WC II/VVD 
proteins were each diluted to 7 mg/mL, mixed in a 1:1 ratio and allowed to 
incubate on ice for 1 h. 
All robotic screens were set up using a 1:1 ratio of protein to well solution 
with a 1 μL total drop volume at RT.  Screens were checked every 4 days for 
three weeks, then once monthly for several months. 
Inspection of the manual and robotic screens showed that the vast majority 
of drop conditions (>96%) resulted in a heavy (dark gray/brown) precipitate 
relative to clear drops for higher concentrations screened.  This ratio was 
observed to significantly decrease with decreasing concentration and the addition 
of a reductant (TCEP or DTT), resulting in a larger fraction drops containing 
medium grey precipitant. 
1.3.3  Approach Taken to Identifying New Variants 
 As seen in Figure 1.3.1.3, while methods to improve the soluble 
expression of N. crassa WC II (179-500) were successful, SDS-PAGE gel 
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analysis showed relatively low protein enrichment due to the formation of 
irreversible high molecular aggregates and protein fragmentation.  This 
observation coupled with the failure to obtain a crystal from screening efforts, 
underscored the need for new variants. 
With this in mind, design of soluble transcriptional activator variants for N. 
crassa, P. blakesleeanus, T. atroviride and C. neoformans incorporated a variety 
of bioinformatic methods to evaluate domain-based identification, sequence 
conservation and secondary structural predictions for identification of potential 
truncations in the proteins domain architecture [65-67].  Once identified, variants 
were systemically PCR cloned, expressed in E. coli and purified for structural 
determination. 
For evaluation of the primary sequence, a comparison of related 
sequences was made to those identified using the NCBI protein-protein Iterated 
Basic Local Alignment Search Tool (blastp), Conserved Domain Database (CDD) 
and the Pfam domain database.  Returned values from the CDD searches are 
reported values from Specific Hits in the database.  For each of the submitted 
sequences, the Pfam query returned significant Pfam-A hits, which are generated 
from a manually annotated library that acts as a seed during database searches 
[65]. 
Secondary structural predictions were obtained from the Jpred 3 web 
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server, which uses the Jnet algorithm [68] to predict α-helices, β-strands and 
coils from submitted sequences.  Additional secondary structural predictions of α-
helices and β-strands, low-complexity and disordered regions, as determined by 
DISOPRED2 [69] and SEG [52], were provided by the XtalPred web server.  
Another feature offered by XtalPred is the comparison the target proteins 
biochemical and biophysical features to the TargetDB [70], which is a target 
registration database for tracking submitted progress made worldwide on 
structural genomics projects.  From these comparisons, XtalPred generates 
probability distributions and a prediction of the proteins crystallizability. 
1.3.4  N. crassa WC II Primary Sequence Analysis 
As a first step in identifying potential truncation points in the N. crassa WC 
II protein, the full-length sequence (1-530) was submitted to Pfam and CDD for 
analysis of the domain architecture.  From this search, both databases identified 
a PAS fold and GATA type zinc finger domain from homology to database 
entries.  Pfam identified residues for PAS (186-263) and zinc finger (468-503) 
domains from comparison to, returned Pfam closely matched CDD output, which 
returned (186-255) and (467-497) respectively.  Also observed was a conserved 
Nuclear Localization Signal (NLS) from (456-461) comprising residues KKKKIK 
[71].  Conserved residues were identified from the alignment of non-redundant 
protein sequences using a blastp search on the NCBI web site.  ClustalW 
alignment of selected sequences indicated the presence of conserved residues 
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N- and C-terminal to the identified PAS domain (not shown).  This conservation is 
reflected in an ESPript web server alignment of homologs studied with N. crassa 
(numbered), where partially conserved residues are denoted with red letters in a 
blue box and strictly conserved residues as white letters on a red background 
(Figure 1.3.1.4).  From these alignments, a conserved sequence N-terminal to 
the identified PAS domain was revealed from (154-174). 
A BLAST search of structures deposited in the PDB using the Protein Data 
Bank proteins(PDB) database, failed to identify structures with homology to the 
conserved N-terminal residues.  However, the search returned PAS structures 
with sequence identity (22-40%) to the C-terminal residues within alignments that 
ended between residues Ile250 to Ile355. 
To further aid in the design of new variants, the primary sequence was 
submitted for secondary structural predictions.  Results from Jpred3 analysis 
indicated residues likely to form α-helices (red) and β-strands (yellow) both N- 
and C-terminal to the identified PAS domain (Figure 1.3.1.5).  Also predicted was 
an extended helical region (284-323) followed by alternating α-helices and β-
strands extending of Ile437. 
Secondary structural predictions from XtalPred were similar to results 
obtained from Jpred3, with an α-helix starting at the N-terminal side of the PAS 
domain (154-172), as well as C-terminal secondary structures for (381-389) and 
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Figure 1.3.1.4  ClustalW Alignment of N. crassa WC II with Studied Homologs.  An 
alignment of the full-length N. crassa WC II (numbered), T. atroviride BLR-2, P. 
blakesleeanus MADB and C. neoformans WC II primary sequences shows partial (red 
font) and strict conservation (white font with red highlighting) starting Ala96, N-terminal 
to the Pfam identified PAS domain (186-263) and continuing to the C-terminally end of 
the zinc finger (468-503).
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Figure 1.3.1.5  Jpred3 Analysis of the Full-length N. crassa WC II Primary 
Sequence.  Secondary structural analysis of N. crassa WC II predict α-helices (red) and 
β-strands (blue) starting at Asp114 and continuing C-terminally to the Pfam identified 
zinc finger (468-503).  Also observed is an extended helical region predicted 
immediately N- and C-terminal to the identified PAS domain (186-263). 
 
(410-416).  XtalPred also evaluated the submitted sequence for low-complexity 
and disordered regions using SEG [52] and DISOPRED [69] respectively.  These 
results indicated a region of low-complexity (312-323) (italicized), a coiled coil 
region (296-323) (bold) and an almost continuous region of disorder from Glu317 
to the C-terminal zinc finger (underlined) as seen in Figure 1.3.1.6. 
To take advantage of the XtalPred crystallizability prediction feature, the 
primary sequence starting at residues Ser154 and Gln174 was systematically 
extended to include each of the conserved residues and predicted secondary  
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Figure 1.3.1.6  XtalPred Analysis of N. crassa WC II (179-500).  Secondary structural 
analysis of the full-length primary sequence predict α-helices (red), β-strands (blue), as 
well as a low-complexity (itializied) (312-323) and disordered (underlined) regions both 
N- and C-terminal identified PAS core.  Analysis also suggests the presence of a coiled 
coil (bold) region (296-323) C-terminal to the Pfam identified PAS domain (186-263).  
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elements C-terminal to the PAS domain.  Crystallizability scores returned from 
this prediction screen (not shown) were unchanged for fragments starting at 
Ser154 of Gln174, however, differences were observed when the C-terminal end 
was varied.  From these submissions, XtalPred returned the highest 
crystallizability prediction scores (suboptimal to average) for fragments ending 
between residues Met280 to Glu320 and the lowest scores (very difficult) for 
longer fragments up to Asp450. 
From bioinformatic evaluation of the N. crassa primary sequence, three 
new variants (154-285, 154-312, 154-323) were generated for expression testing 
(Figure 1.3.1.7).  The starting residue for the variants was based on incorporation 
of conserved residues predicted to form an α-helix N-terminal to the start of the 
canonical PAS fold (Aβ, Bβ, Cα, Dα, Eα, Fα, Gβ, Hβ and Iβ) [11, 72].  Selection 
of the C-terminal ending residues were based on partitioning of an extended C- 
terminal α-helix while minimizing the inclusion of residues predicted in low-
complexity and disordered regions. 
1.3.4.1  N. crassa WC II PAS Variants 
In each case, 25 g of cellular material expressing the variant proteins was 
purified using conditions previously established for N. crassa WC II (179-500).  
Total soluble protein in purification steps for each of the three variants was 
quantified using SDS-PAGE gel analysis and the Bradford assay. 
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Figure 1.3.1.7  Summary of N. crassa WC II PAS Domain Containing Variants.  
Colored bars illustrate inclusion of a bioinformatically predicted PAS (186-263), coiled 
coil (296-313), low-complexity region (212-323), while omitting the C-terminal NLS (456-
461) and zinc finger (468-503). 
 
Results from analysis of N. crassa WC II (154-285) and (154-323) IMAC 
elutions indicated low soluble protein expression (not shown).  Significantly 
higher levels of soluble protein were observed with (154-312), however the 
protein lacked stability in solution at 4 °C as it repeatedly precipitated (Figure 
1.3.1.8).  The first precipitation occurred during the IMAC elution and then again 
after 15 min at 4 °C.  After each precipitation, the protein was centrifuged for 10 
m at 13,000 rpm and supernatant removed.  Following the second precipitation, 
the supernatant was subjected to SEC purification, which showed multiple low 
absorbance peaks and lacked a well defined peak corresponding to the expected 
elution value for an apparent dimer (Figure 1.3.1.8). 
SEC purification of (154-312) using a Superdex 75 prep grade column also 
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Figure 1.3.1.8  N. crassa WC II (154-312) Displays Low Solubility Following IMAC 
and SEC Purification.  SDS-PAGE gel analysis of IMAC elution fractions show bands 
corresponding to the protein theoretical 20 kDa molecular weight, however, the protein 
precipitated immediately after IMAC elution.  The SEC elution profile of supernatant 
from centrifugation of pooled IMAC elution fractions following precipitation indicates the 
absence of a defined elution peak consistent with the expected molecular weight for a 
38 kDa dimer.  A low absorption peak eluting at 243 mL is suggestive of a species with 
an apparent 19 kDa molecular weight, which corresponds to the value expected for a 
monomer. 
 
showed multiple peaks in the elution profile with a peak corresponding to the 
elution value expected for an apparent monomer (not shown), similar to the 
elution profile, as seen in Figure 1.3.1.8. 
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Given the low soluble protein expression observed in variants terminating 
near the end of the predicted PAS domain, an alternative approach was 
undertaken to extend fragments from Gln174 up to the NLS.  Inclusion of these 
residues, which might provide interactions needed to stabilize the protein, 
resulted in the generation of several new truncation constructs (residue ranges: 
174-445, 174-449, 174-453 and 174-455) for study (Figure 1.3.1.9). 
Expression and purification of 25 g preparations followed methods 
described for N. crassa WC II (179-500) with the following exceptions: addition of 
5 mM DTT and TCEP, reduction of the induction temperature to 13 °C with a 1 h 
equilibration before induction.  These changes resulted in robust soluble protein 
expression for each of the tested variants.  SDS-PAGE analysis of SEC 
purification showed minimal formation of irreversible high molecular weight 
aggregates, however, as seen in Figure 1.3.2, low molecular weight bands 
attributed to fragmentation were observed. 
To screen each of the generated N. crassa WC II PAS variants for 
crystallization, a similar approach as described for (179-500) was undertaken.  
Manual screening was conducted with Crystal Screen 1 and 2, Wizard Classic 1, 
2, 3, 4 and custom grid screens using protein at stock concentration as well as 
those dilute to 50 and 25% using GFB at 4 and 17 °C.  For each of the tested 
conditions, a ratio of 2 µL protein to 2 µL well condition was used.  Stock protein 
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Figure 1.3.1.9  Summary of N. crassa WC II PAS and Zinc finger Domain 
Containing Variants.  Colored bars illustrate inclusion of a bioinformatically predicted 
PAS (186-263), coiled coil (296-313), low-complexity region (212-323).  Also shown is 
N. crassa WC II, which contains the predicted PAS domain, coiled coil, low-complexity 
region, nuclear localization signal (NLS) (456-461) and C-terminal zinc finger (468-503). 
 
was robotically screening using Hampton Crystal Screen 1 and 2, PEG/Ion 
Screen 1 and 2, MembFac, Crystal Screen Lite, Wizard Classic 1, 2, 3, 4 and 
NeXtal Tubes JCSG Core Suite I, II using a ratio of 0.5 µL protein to 0.5 µL well 
condition at RT. 
1.3.5  N. crassa WC I Variants 
N. crassa WC I variants containing the C-terminal PAS (PAS C) domain 
(705-918) and PAS C with the C-terminal zinc finger domain (705-1000) [62] 
were provided by co-workers for study (Figure 1.3.2.1).  WC I (705-918) was 
generated following expression and purification methods described for N. crassa 
WC II (174-455).  SDS-PAGE gel analysis of SEC elution fractions from 25 g 
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Figure 1.3.2  Extension of PAS Variants Shows Improved Stability in Solution.  
SDS-PAGE gel analysis of N. crassa WC II (174-455) SEC elution fractions show bands 
corresponding to the proteins theoretical 34 kDa molecular weight.  A principle SEC 
elution peak at 199 mL is suggestive of a dimeric species with an apparent molecular 
weight of 72 kDa.  Eluted protein selected for concentration and crystallization 
screening are denoted with red bars on the SEC elution profile and corresponding SDS-
PAGE gel. 
 
preparations showed significant soluble protein expression with minimal high and 
low molecular weight banding (Figure 1.3.2.2).  Selected fractions from SEC 
purification were collected and concentrated with samples obtained at 2, 4 and 6 
mg/mL. 
N. crassa WC I (705-918) was screened for crystallization at 2, 4, and 6 
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Figure 1.3.2.1  Summary of N. crassa WC I Domain Architecture.  The WC I (705-
918) variant contains the C-terminal PAS domain (PAS C) while WC I (705-1000) 
includes the PAS C, coiled coil domain (CC), nuclear localization domain (NLS) and 
zinc finger (bottom), with both variants omitting the LOV and putative activation domains 
(AD) bracketed with red bars. 
 
mg/mL using Crystal Screen 1, 2 and Wizard Classic 1, 2, 3, 4 at 4 °C with 2 and 
4 µL total drop volumes.  Screens were checked daily for three weeks, with the 
majority of conditions showing a transition from medium to heavy precipitation 
with increasing concentration. 
To screen N. crassa WC I (705-918) and WC II (174-455) for crystallization 
as a complex, stock WC I at 6 mg/mL was mixed in an equimolar ratio with WCII 
and tested using Crystal Screen 1 at RT.  Upon addition to the well conditions, 
the protein immediately precipitated.  The solution was then diluted with an equal 
volume of GFB and showed the same result.  Protein was then diluted to 0.75 
and 1.5 mg/mL with GFB then screened at 4 °C using Crystal Screen 1 and 2, 
Crystal Screen Lite and Wizard Classic 1, 2, 3, 4 in hanging drops with 2 and 4 
µL total drop volumes.  Additional screening was conducted with variation in the 
44 
 
 
Figure 1.3.2.2  SEC Purification of N. crassa WC I (705-918) Shows a Defined 
Elution Peak.  SDS-PAGE gel analysis of SEC elution fractions show soluble protein 
corresponding to the proteins 25 kDa theoretical molecular weight.  The SEC elution 
profile has a principle elution peak at 210 mL, suggestive of a species with a 38kDa 
apparent molecular weight, smaller than the predicted 50 kDa molecular weight 
associated with a dimer.  Red bars on SDS-PAGE gel and SEC elution profile indicated 
protein selected for concentration and crystallization screening. 
 
stoichometric ratio, first using an excess of WC I then WC II at 4, 2, and 1:1.  In 
both cases, the protein at a constant concentration was fixed at 0.6 mg/mL at 
screened using the hanging drop method (4 µL total drop volume).  Conditions 
were checked daily for three weeks, with the majority of drop conditions for N. 
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crassa WC I (705-918) and WC II (174-455) mixtures either clear drops or light 
precipitate.  
Preparation of N. crassa WC I (705-1000) used the same method as 
described for WC II (174-455), with protein samples taken at 2, 3 and 5 mg/mL 
during concentration.  SDS-PAGE gel analysis of SEC elution fractions (Figure 
1.3.2.3) showed a band at 35 kDa, closely matching the proteins theoretical 
molecular weight of 34 kDa.  SDS-PAGE gel analysis also indicated the 
presence of significant low molecular weight banding, which increase when 
stored for 16 h at 4 °C (not shown). 
N. crassa WC I (705-1000) was screened for crystallization at 0.75, 1.5 
and 2.5 mg/mL using the approach taken for N. crassa WC I (705-918).  Results 
from screening showed a transition from clear/light granular precipitate for the 
lowest concentration to a majority of drops medium granular precipitate for higher 
concentration. 
In an effort to screen N. crassa WC I (705-1000) with WC II (179-500) 
together, the proteins were mixed at 4 °C in an approximately equimolar ratio at 3 
mg/mL.  Upon mixing the proteins with an identical buffer composition, the 
solution immediately precipitated.  The proteins were then mixed at 1.5 and 1 
mg/mL and in each case the protein immediately precipitated.  Following 
precipitation, the samples were centrifuged at 4 °C for 10 m and 13,000 rpm. 
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Figure 1.3.2.3  Purification of N. crassa WC I (705-1000) Shows Soluble Protein.  
SDS-PAGE gel analysis of SEC elution fractions show soluble protein corresponding to 
the theoretical 34 kDa molecular weight.  The SEC elution profile indicates a broad 
elution peak suggestive of multiple oligomeric states in exchange at 198 mL.  This 
elution value is also suggestive a species with an apparent molecular weight of 74 kDa, 
slightly larger than the predicted 68 kDa theoretical molecular weight for N. crassa WC 
II (705-1000) dimer. 
 
The supernatant was removed and the concentration was tested using the 
Bradford assay, which detected no protein in the supernatant. 
1.3.6  P. blakesleeanus MADB Primary Sequence Analysis 
To facilitate bioinformatic analysis for P. blakesleeanus as described for N. 
crassa WC II, a search of the Pfam and CDD databases using the full-length 
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primary sequence was first performed.  From this search a PAS fold from (62-
136) and (43-145) as well as a GATA type zinc finger domain from (313-348) and 
(312-349) were identified (reported respectively).  Additionally, a NLS sequence 
was observed from (301-306).  To evaluate sequence homology, an alignment of 
P. blakesleeanus (numbered) with the studied homologs (Figure 1.3.2.4) was 
generated.  This alignment showed partial and strict residues conservation from 
Thr30 to Arg50, N-terminal to the identified PAS domain. 
From Jpred3 analysis of the primary sequence, secondary structural 
predictions suggested the presence of an α-helix N-terminal to the PAS domain 
(26-50).  From previous studies, the presence of an α-helix N-terminal to the PAS 
domain (N-cap), which has been suggested to facilitate stabilizing interactions 
[73] was predicted, as well as α-helical structures extending from the C-terminal 
end of the PAS domain to the zinc finger (Figure 1.3.2.5). 
XtalPred analysis further predicted α-helices and β-strands both N- and C-
terminal to the PAS domain with an α-helical region from (28-48) and disordered 
regions both N- and C-terminal to the identified PAS fold as well as a coiled coil 
domain (156-183) and low-complexity region C-terminal to the PAS core (Figure 
1.3.2.6). 
Based on conclusions drawn from bioinformatic analysis of the N. crassa 
primary sequence and from application of bioinformatic methods to the P.
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Figure 1.3.2.4  ClustalW Alignment of P. blakesleeanus MADB with Studied 
Homologs.  An alignment of full-length P. blakesleeanus MADB primary sequence 
(numbered) with N. crassa WC II, T. atroviride BLR-2 and C. neoformans WC II shows 
partial (red font) and strict conservation (white font with red highlighting) starting at Glu2 
N-terminal to the Pfam identified PAS (62-136) and continuing C-terminally to the zinc 
finger (313-348).  
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Figure 1.3.2.5  Jpred3 Secondary Structural Predictions for the P. blakesleeanus 
MADB Primary Sequence.  Secondary structural analysis of the full-length P. 
blakesleeanus MADB primary sequence predict α-helices (red) and β-strands (blue) 
starting at Pro19, N-terminal to the Pfam identified PAS domain (62-136) and continuing 
to the C-terminal zinc finger (313-348). 
 
Figure 1.3.2.6  XtalPred Predictions for P. blakesleeanus MADB.  Secondary 
structural analysis of the full-length P. blakesleeanus MADB primary sequence predict 
α-helices (red), β-strands (blue), as well as low-complexity (183-195, 202-217) 
(itializied) and disordered (underlined) regions both N- and C-terminal identified PAS 
core.  Also predicted is presence of a coiled coil (bold) region (156-183) C-terminal to 
the Pfam identified PAS domain (62-136).
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blakesleeanus MADB primary sequence, six PAS domain containing variants 
were generated (Figure 1.3.2.7) incorporating the predicted N-terminal helix, 
starting at Pro27 and extending C-terminally, resulting in (27-181, 27-286, 27-
289, 27-293, 27-297 and 27-300).  An additional variant including the proteins 
PAS domain and C-terminal zinc finger (27-346), based on homology to N. 
crassa WC II (179-500) was also generated for soluble protein expression. 
1.3.6.1  P. blakesleeanus MADB Variants 
From initial screening efforts, SDS-PAGE gel analysis of small-scale 
expression tests for each of the seven generated variants failed to show any 
bands, in either the soluble or insoluble fractions, corresponding to the protein 
theoretical molecular weight.  In an effort to produce P. blakesleeanus MADB 
variants in quantities sufficient for crystallization screening, 25 g preparations 
were expressed and purified as described for N. crassa WC II (179-500).  
Analysis of IMAC elution fractions from these preparations, using SDS-PAGE, 
mirrored results from the small-scale tests with protein at or below the limit of 
detection for the Bradford assay and SDS-PAGE gel as evidence by a lack of 
detected protein and an absence of bands corresponding to the theoretical 
molecular weight respectively (not shown).  The highest observed soluble protein 
expression was seen with the shortest PAS variant (27-181); however the protein 
precipitated during IMAC elution at 4 °C.  Supernatant isolated from a 
centrifugation performed for 10 min at 13,000 rpm was shown to have a final
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Figure 1.3.2.7  Summary of P. blakesleeanus MADB PAS and Zinc finger Domain 
Containing Variants.  Colored bars illustrate inclusion of bioinformatically predicted 
PAS (62-136), coiled coil (156-183), low-complexity regions.  Also shown is P. 
blakesleeanus MADB (27-346), which contains the predicted PAS domain, coiled coil, 
low-complexity regions, as well as the NLS (301-306) and C-terminal zinc finger (313-
348). 
 
concentration of 1.5 mg/mL (not shown). 
Crystallization screening was not performed on these preparations. 
1.3.7  T. atroviride BLR-2 Primary Sequence Analysis 
 Bioinformatic methods used in the analysis of the N. crassa primary 
sequence were extended to T. atroviride for the generation of soluble WC II 
variants.  A search of the proteins primary sequence to Pfam and CDD 
databases identified a PAS fold from (163-239) and (163-232) as well as a GATA 
type zinc finger domain from (430-465) and (429-478) respectively.  A primary 
sequence alignment of T. atroviride (numbered) with the studied homologs 
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(Figure 1.3.2.8), showed partial and strict residues conservation N-terminal to the 
identified PAS domain starting at Asn131 and continuing to Ser151. 
Secondary structural analysis with Jpred3 predicted an α-helix (127-150) 
just N-terminal to the PAS domain with α-helical structures predicted to extend to 
from the C-terminal end of the PAS domain to Lys420 (Figure 1.3.2.9).  XtalPred 
analysis returned α-helices and β-strands both N- and C-terminal to the PAS 
domain (Figure 1.3.3) with an α-helical region predicted from (126-149).  
Predictions of low-complexity and disordered regions were predicted outside of 
the PAS core with a coiled coil domain predicted for (273-304). 
Based on analysis of the T. atroviride primary sequence and previous 
results from expression of N. crassa variants, five PAS domain containing 
fragments were generated incorporating the predicted N-terminal helix starting at 
Leu133 and extending C-terminally resulting in (133-318, 133-411, 133-415 and 
133-417).  An additional variant including the proteins C-terminal zinc finger (133-
467), based on homology to N. crassa WC II (179-500) was also generated for 
soluble protein expression (Figure 1.3.3.1). 
1.3.7.1  T. atroviride BLR-2 Variants 
Similar to results seen with N. crassa WC II (154-285) and (154-323), T. 
atroviride BLR-2 (133-297) SDS-PAGE gel analysis showed no bands in IMAC 
elution fractions matching the proteins theoretical molecular weight (not shown).
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Figure 1.3.2.8  ClustalW Alignment of T. atroviride BLR-2 with Studied Homologs.  
An alignment of the full-length primary sequence for T. atroviride BLR-2 (numbered) 
with full-length N. crassa WC II, P. blakesleeanus MADB and C. neoformans WC II 
shows partial (red font) and strict conservation (white font with red highlighting) starting 
at Glu96 N-terminal to the Pfam identified PAS (163-239) and continuing to the end of 
the C-terminal zinc finger (430-465
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Figure 1.3.2.9  Jpred3 Analysis of T. atroviride BLR-2 Primary Sequence.  
Secondary structural predictions for the full-length T. atroviride BLR-2 primary sequence 
predict α-helices (red) and β-strands (blue) starting at Ala23 and continuing to the C-
terminal zinc finger (430-465).  Also observed is an extended α-helix N- and C-terminal 
to the Pfam identified PAS domain (163-239). 
 
This contrasted results from the longer PAS variants (133-318, 133-411, 133-415 
and 133-417), which showed a higher level of soluble protein expression in 
purification steps. 
SDS-PAGE analysis of IMAC elution fractions for (133-318) showed a 
principle band at 23 kDa, which matches theoretical molecular weight as well as 
low molecular weight bands (Figure 1.3.3.2).  The SEC profile for protein purified 
using a HiLoad 26/60 Superdex 75 column, showed a peak eluting at 146 mL 
suggestive of a species with an apparent molecular weight of 44 kDa, which 
closely matched the expected value for a 46 kDa dimer (Figure 1.3.3.2).  Also
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Figure 1.3.3  XtalPred Analysis of T. atroviride BLR-2.  Secondary structural 
predictions for the full-length T. atroviride BLR-2 primary sequence predict α-helices 
(red), β-strands (blue), as well as low-complexity (itializied) and disordered (underlined) 
regions both N- and C-terminal identified PAS core.  Analysis also suggests and the 
presence of a coiled coil (bold) region (273-304) at the C-terminal to the Pfam identified 
PAS domain (163-239).  
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Figure 1.3.3.1  Summary of T. atroviride BLR-2 PAS and Zinc finger Domain 
Containing Variants.  Colored bars illustrate inclusion of bioinformatically predicted 
PAS (163-239), coiled coil (273-304) and low-complexity regions, as well as T. 
atroviride BLR-2 (133-467), which contains the NLS (418-423) and C-terminal zinc 
finger (430-465). 
 
observed was a second overlapping peak eluting at 163 mL, suggestive of a 23 
kDa species. 
SDS-PAGE gel analysis of SEC elutions fractions showed a 23 kDa band 
for both peaks with a gradual increase in low molecular weight banding for 
fractions containing the 163 mL peak (not shown).  Additionally, resolution of 
these peaks in SEC purifications were unaffected by variations in extraction and 
gel filtration buffer composition (not shown).  As observed in Figure 1.3.3.2, T. 
atroviride BLR-2 (133-318) concentrated to 5 mg/mL showed the low molecular 
weight bands, reducing the protein purity below levels desired for crystallographic 
studies. 
Consistent with results from (133-318), IMAC and SEC purification for the 
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Figure 1.3.3.2  Purification of T. atroviride BLR-2 (133-318).  SDS-PAGE gel 
analysis of IMAC elution fractions show bands corresponding to the proteins theoretical 
23 kDa molecular weight.  SEC purification shows a principle elution peak at 146 mL 
suggestive of a species with an apparent molecular weight of 44 kDa, which co-elutes 
with a 163 mL peak (26 kDa apparent molecular weight).  Low molecular weight bands 
are observed from SDS-PAGE analysis of protein concentrated to 5 mg/mL (right).  
Eluted protein selected for concentration and crystallization screening is denoted with 
red bars on the SEC elution profile. 
 
longer T. atroviride BLR-2 PAS variants (133-411, 133-415 and 133-417) showed 
low molecular weight bands and a co-eluting peak in elution fractions.  
Interestingly, the ratio of both relative to the principle elution species was 
reduced with as increasing variant length (not shown), suggesting the additional 
residues provided interactions needed for formation of a stable dimer. 
As noted, preparation of T. atroviride BLR-2 (133-467), containing both the 
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PAS and zinc finger was preformed.  From SDS-PAGE gel analysis of IMAC 
elution fractions (Figure 1.3.3.3), a band corresponding to the proteins 39 kDa 
theoretical molecular weight was observed. 
 
Figure 1.3.3.3  Purification of T. atroviride BLR-2 (133-467).  SDS-PAGE gel 
analysis of IMAC elution fractions show bands corresponding to the proteins theoretical 
39 kDa molecular weight.  A principle SEC elution peak at 186 mL is suggestive of a 
species with an apparent molecular weight of 108 kDa, larger than the proteins 
theoretical 78 kDa molecular weight.  Red bars on the SEC elution profile and 
accompanying SDS-PAGE gel denote protein selected for concentration to 5 mg/mL for 
crystallization screening. 
 
Evaluation of the SEC elution profile showed a principle elution peak at 
186 mL, suggestive of a species with an apparent molecular weight of 108 kDa, 
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larger than the 78 kDa value expected associated with a dimer.  Also observed 
was a decrease in low molecular weight bands relative to the principle band as 
seen in protein concentrated to 5 mg/mL (Figure 1.3.3.3). 
Crystallization screening of T. atroviride BLR-2 variants was performed 
using methods described for N. crassa WC II (179-500).  Results from these 
screens showed approximately 90% light precipitate:10% phase separation for 
PAS domain containing variants.  The same precipitate to phase separation ratio 
was observed for the variants containing the PAS and zinc finger domain, 
however approximately 30% of the precipitated drops were heavy (dark gray).  In 
all cases, the overall percentage of wells showing heavy precipitate increased 
with concentration. 
1.3.8  C. neoformans WC II Primary Sequence Analysis 
 Application of bioinformatic analysis for generation of C. neoformans WC II 
variants followed the approach taken for N. crassa WC II.  From a search of the 
primary sequence using Pfam and CDD, a PAS (74-122 and 70-133) and zinc 
finger domain (348-383 and 347-383) was identified (reported respectively).  As 
shown in an alignment of C. neoformans (numbered) with the homologs studies 
(Figure 1.3.3.4), sequence homology N-terminal to the identified PAS domain 
showed partial and strict residues conservation from Asn26 to Val46, N-terminal 
to the identified PAS domain. 
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 Secondary structural analysis from Jpred3 suggested the presence of an 
intermittent α-helical structure N-terminal to the identified PAS domain (26-55) 
with α-helices and β-strands also predicted to extend from the C-terminal end of 
the PAS domain to Asp282 (Figure 1.3.3.5).  XtalPred predicted α-helices and β-
strands both N- and C-terminal to the PAS core with an α-helical region from (24-
45) (Figure 1.3.3.6).  Further, predicted were disordered regions both N- and C-
terminal to the PAS fold, a coiled coil domain (254-281) and a discontinuous low-
complexity region (259-302). 
From bioinformatic analysis of the C. neoformans WC II primary sequence, 
variants starting at Asn26, incorporating the predicted α-helix N-terminal to the 
identified PAS domain were extended C-terminally to the zinc finger resulting in 
(26-250, 26-276, 26-282, 26-289, 26-301, 26-306, 26-311, 26-315, 26-317, 26-
320, 26-323, 26-329 and 26-340). 
Additional variants including the proteins C-terminal zinc finger based on 
homology to N. crassa WC II (179-500) was also generated for soluble protein 
expression resulting in (26-378, 26-380 and 26-383), as well as full-length protein 
(1-392) as shown in Figure 1.3.3.7. 
1.3.8.1  C. neoformans WC II Variants 
As seen in the SDS-PAGE gel analysis of C. neoformans WC II (26-250), 
purified using methods described for N. crassa WC II (174-455), a band closely
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Figure 1.3.3.4  ClustalW Alignment of C. neoformans WC II with Studied 
Homologs.  An alignment of the full-length primary sequences for C. neoformans WC II 
(numbered), N. crassa WC II, T. atroviride BLR-2 and P. blakesleeanus MADB shows 
partial (red font) and strict conservation (white font with red highlighting) starting at Glu9 
N-terminal to the Pfam identified PAS (74-122) continuing C-terminally to the zinc finger 
(348-383). 
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Figure 1.3.3.5  Jpred3 Analysis of C. neoformans WC II Primary Sequence.  
Secondary structural predictions for the full-length C. neoformans WC II primary 
sequence predict α-helices (red) and β-strands (blue) starting at Met1 and continuing to 
the C-terminal zinc finger. 
 
matching the proteins 26 kDa theoretical molecular weight was observed (Figure 
1.3.3.8).  Additionally, protein concentrated to 67 mg/mL, from collected SEC 
elution fractions showed purity sufficient for crystallization screening as SDS-
PAGE gels analysis as indicated minimal high and low molecular weight band 
formation. 
The SEC elution profile for (26-250) showed a principle peak at 229 mL 
suggestive of a species with an apparent 29 kDa molecular weight, close to the 
value expected for a monomer.  This result contrasted the observation that the 
SEC elution profiles for each of the longer C. neoformans WC II variants all 
displayed elution peaks consistent with formation of an apparent dimer (not 
shown). 
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Figure 1.3.3.6  XtalPred Analysis of C. neoformans WC II.  Secondary structural 
predictions for the full-length C. neoformans WC II primary sequence predict α-helices 
(red), β-strands (blue), as well as discontinuous low-complexity (259-302) (itializied) and 
disordered (underlined) regions both N- and C-terminal identified PAS core.  Analysis 
also suggests and the presence of a coiled coil (bold) region (254-281) at the C-terminal 
to the Pfam identified PAS domain (74-122).
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Figure 1.3.3.7  Summary of C. neoformans WC II PAS and Zinc finger Domain 
Containing Variants.  Colored bars illustrate variants that either include or exclude the 
bioinformatically predicted PAS (74-122), coiled coil (254-281), low-complexity regions 
and C-terminal zinc finger (348-383). 
 
Based on results obtained from purification of the C. neoformans WC II 
variants, the full-length protein (1-392) was generated for study.  As seen in 
Figure 1.3.3.9, bands corresponding to the proteins 45 kDa theoretical molecular 
weight are observed in IMAC and SEC elutions.  Similar to results from the 
truncated variants, the protein shows relatively little formation of high and low 
molecular weight bands in SDS-PAGE gel analysis when purified using methods 
described for N. crassa WC II (174-455). 
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Figure 1.3.3.8  Purification of C. neoformans WC II (26-250).  SDS-PAGE gel 
analysis of the IMAC elution shows a band corresponding to the proteins theoretical 26 
kDa molecular weight.  From SEC purification, the protein was observed to elute at 229 
mL, suggestive of a 29 kDa monomeric species.  SEC elutions selected for and 
subsequently concentrated to 67 mg/L for crystallization screening is denoted with red 
bars on the SEC elution profile. 
 
Crystallization screening of C. neoformans WC II proteins was performed 
using methods described for N. crassa WC II (179-500).  Results from these 
screens showed approximately 30-40% phase separation accompanying an 
equal distribution of clear and precipitated drops for PAS domain containing 
variants.  An approximate ratio of 70% phase separation to clear and precipitated 
drops was observed for the variants containing the PAS and zinc finger domain. 
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Figure 1.3.3.9  Purification of C. neoformans WC II (1-392).  SDS-PAGE gel analysis 
of IMAC and SEC elution fractions show a band corresponding to the proteins 45 kDa 
theoretical molecular weight.  A principle SEC elution peak at 194 mL is suggestive of a 
species with an apparent molecular weight of 90 kDa, suggestive of a dimer.  Eluted 
protein selected for concentration and crystallization screening are denoted with red 
bars on the SEC elution profile and corresponding SDS-PAGE gel. 
 
1.3.9  C. neoformans WC I Variants 
 Design of C. neoformans White collar I variants was based on a 36 amino 
acid N-terminally truncated N. crassa VVD (VVD-36) fragment previously 
crystallized by coworkers [74].  From alignment of VVD-36, N. crassa WC I and 
C. neoformans WC I LOV domains, His474 in the C. neoformans primary 
sequence is shown to correspond to the start of VVD-36 (Figure1.3.4). 
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Figure 1.3.4  ClustalW Alignment of LOV Domains from N. crassa VVD, WC I and 
C. neoformans WCI Show Residue Conservation.  An alignment of the full-length 
primary sequence for N. crassa Vivid (VVD) (numbered), N. crassa WC I and C. 
neoformans WC I shows partial (red font) and strict conservation (white font with red 
highlighting) for the proteins Light Oxygen Voltage (LOV) domain.  From the alignment 
C. neoformans His474 is shown to correspond to His37 in the VVD sequence.  The 
secondary structure shown above the sequence alignment, which denotes α-helices, β-
strands and turns as determined from the deposited N-terminally truncated VVD-36 
crystal structure (PDB: 2PD7). 
 
To generate additional variants, Ile456 and Pro431, which both correspond 
to Asp24 in the VVD-36 sequence, were also made.  In each case, the variants 
were C-terminally truncated at Val637, which corresponds to the end of the VVD-
36 sequence. 
 For each of the designed variants, 25 gram preparations were expressed 
and purified using conditions detailed for VVD-36.  From SDS-PAGE gel analysis 
of IMAC elution fractions, no bands corresponding to the variants theoretical 
molecular weight were observed (not shown). 
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1.4  Discussion 
 To facilitate the study of White Collar transcriptional activators, variants 
based on bioinformatic analysis of the proteins domain architecture were 
selected for expression and purification.  From these studies, fragments 
containing the PAS and zinc finger domains were generated in quantities and 
purity sufficient for biophysical characterization as discussed in Chapter 2. 
 While results from the bioinformatic methods used were similar to those 
previously described in identification of the proteins PAS, coiled coil, low-
complexity and zinc finger regions [8, 37, 39, 62, 71, 75], it was also observed 
that extended variants, which include conserved residues C-terminal to the 
identified PAS domains, demonstrated greater solubility and eluted with apparent 
volumes suggestive of apparent dimers in SEC purifications. 
With these observations in mind, N. crassa WC I and II sequences were 
compared to the known crystal structures of the M. musculus heterodimeric 
CLOCK:BMAL1 transcriptional activator complex [10], as well as the 
homodimeric negative clock elements Period 2 homolog from M. musculus [76] 
and Period from D. melanogaster [35].  To facilitate this alignment, the WC I and 
II sequences were first compared with the canonical PAS A core (Aβ, Bβ, Cα, 
Dα, Eα, Fα, Gβ, Hβ and Iβ) [10], followed by the PAS B core (Figure 1.4.1).  
From these alignments, WC I (586-705) and (706-806) showed strict and partial 
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Figure 1.4.1  ClustalW Alignment of N. crassa WC I and II Suggest the Presence a 
PAS Repeat.  Alignment of N. crassa WC I (numbered) and II with M. musculus 
CLOCK:BMAL1 (PDB: 4F3L), Period2 (mPERIOD)(PDB: 3GD1) and D. melanogaster 
Period (dPERIOD)(PDB:3RTY) show partial (red font) and strict conservation (white font 
with red highlighting) with each of the proteins core PAS regions.   
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conservation with the known structures PAS A and B cores respectively (Figure 
1.4.2) [10]. 
 
Figure 1.4.2  PAS AB Domain Repeat is Observed in N. crassa White Collar I and 
II.  From CLUSTALW sequence alignments, residue homology between N. crassa WC I 
and II proteins to M. musculus CLOCK, BMAL1, PERIOD2 homolog and D. 
melanogaster PERIOD PAS core regions suggest the presence of a PAS AB repeat. 
 
Interestingly, while previous analysis of the WC II sequence did not predict 
the presence of a PAS AB repeat, alignment of (174-317) to the known structures 
respective PAS A cores shows good sequence conservation for N-terminal 
portion (Aβ, Bβ, Cα, Dα, Eα and Fα), with little homology for the C-terminal 
region (Gβ, Hβ and Iβ).  This alignment compliments the alignment of (325-441) 
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to the PAS B regions, which shows good agreement throughout the entire PAS 
core (Figure 1.4.1).  Results from these alignments suggest the presence of a 
PAS AB repeat in both N. crassa WC I and II similar to the arrangement 
observed in M. musculus CLOCK:BMAL1 and Period proteins from D. 
melanogaster and M. musculus (Figure 1.4.2). 
Based on the results from WC I and II protein variant screening as well as 
bioinformatic analysis of the primary sequence, which suggest the presence of a 
WC I and II PAS AB repeat, further efforts to purify both WC I and II based on the 
putative PAS AB repeats, offers the possibility of furthering our understanding of 
how these proteins associate using biophysical methods such as X-ray 
crystallography or small-angle X-ray scattering. 
To facilitate these studies, WC I PAS domain containing efforts should be 
centered on (585-806), with N- and C-terminal variations that might include 
flanking regions needed for crystallization.  For WC II, PAS only variants should 
focus on (154-445) and (174-445), which extend to the C-terminal end of the 
putative PAS AB repeat and includes or excludes the N-terminal α-helix (putative 
N-cap) respectively.
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CHAPTER 2 
CHARACTERIZATION OF A NEUROSPORA CRASSA WHITE COLLAR PAS 
DOMAIN MEDIATED COMPLEX 
 
2.1  Introduction 
As discussed in Chapter 1, circadian clocks are a common feature among 
biological systems that allow organisms to anticipate diurnal changes in their 
environment.  Central to the N. crassa clock are the White Collar I [1] and II [2] 
(WC I and WC II) transcriptional activators [3], that associate via PAS domains 
[4]  to form a heteromeric complex called the White Collar Complex (WCC) [5].  
Once formed, imperfect GATA-type zinc fingers [5, 6] in the WC proteins bind the 
pseudo-palandromic sequences identified from mutational analysis of the frq 
promoter region (Clock-box) and promote expression of the negative element 
Frequency [7, 8]. 
While considerable work has been done to elucidate the role of the WCC 
in blue-light photoreception and transcription of clock controlled genes as well as 
negative clock elements, relatively little is known about the proteins on the 
molecular level, including the oligomeric state of the WCC, orientation of the PAS 
and zinc finger domains in the complex and how it interacts with the negative 
clock elements Vivid and Frequency. 
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With this in mind, the individual transcriptional activators WC I and II from 
N. crassa, as described in Chapter 1, were copurified allowing for 
characterization of variants containing only the proteins the PAS as well as PAS 
with the C-terminal zinc finger domain using small-angle X-ray scattering.  From 
these studies, we show the formation of a WC I/II PAS mediated complex, 
suggesting the N. crassa WCC may assemble to form a heterotetermeric 
species.  Formation of this species would allow for a single transcriptional 
complex to simultaneously bind four cis-acting pseudo-palandromic sequences 
light-acting response elements identified in the frq promoter region [9]. 
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2.2  Materials and Methods 
2.2.1  Generating WC I and II Proteins for Small-angle X-ray Scattering 
Studies 
 
Expression and purification methods for generation of N. crassa White 
Collar  I C-terminal Per-ARNT-Sim (PAS C) domain [4, 10, 11], amino acid 
residue 705-918 (705-918), PAS C with the C-terminal zinc finger (705-1000) 
[10], as well as N. crassa WC II PAS (174-455) and PAS with the C-terminal zinc 
finger (179-500) variants for small-angle X-ray scattering studies are described in 
Chapter 1. 
2.2.1.1  Purifying WC I/II Proteins 
Approximately equal quantities of each frozen cell pellet were first 
resuspended and mixed on ice with an approximate ratio of 10 mL lysis buffer 
containing 300 mM NaCl, 50 mM Tris pH 7.5, 10 mM imidazole, 10% v/v glycerol, 
2 mM dithiothreitol (DTT) and 5 mM Tris(2-carboxyethyl)phosphine (TCEP) to 
each gram of cellular pellet.  The suspension was then mixed and lysed on ice 
with four alternating 2 s on/2 s off sonication cycles each lasting 30 s.  All 
purification and handling steps from this point were conducted as rapidly as 
possible at 4 °C.  Following sonication, the proteins were centrifuged at 4 °C for 
45 min at 22,000 rpm and the supernatant was first collected, then applied to an 
Ni:NTA Sepharose (Pierce) gravity flow column with a 2 mL bed volume 
equilibrated with lysis buffer for immobilized metal affinity chromatography 
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(IMAC) purification.  Bound protein was washed with 50 column volumes (cv) of 
lysis buffer, followed by 50 cv of a wash buffer containing 300 mM NaCl, 50 mM 
Tris pH 7.5, 20 mM imidazole, 10% v/v glycerol, 2 mM DTT and 5 mM TCEP.  
Bound protein was eluted from the column with elution buffer containing 300 mM 
NaCl, 50 mM Tris pH 7.5, 300 mM imidazole, 10% v/v glycerol, 5 mM DTT and 5 
mM TCEP in 2 mL aliquots.  Fractions containing protein as determined by 
Bradford assay [12] were pooled (10 mL total volume) and loaded onto ÄKTA 
fast protein liquid chromatography instrument (GE Healthcare) with a HiLoad 
26/60 Superdex 200 prep grade gel filtration column (GE Healthcare) equilibrated 
with either 150 mM NaCl, 50 mM Tris pH 7.5, 5% v/v glycerol, 5 mM DTT and 5 
mM TCEP for small-angle X-ray scattering (SAXS) analysis or with 150 mM 
NaCl, 50 mM Tris pH 8.0, 5 mM DTT and 5 mM TCEP for size-exclusion 
chromatography coupled to a multi-angle light scattering (SEC-MALS) detector.  
In all cases, SEC purification was performed using a flow rate of 2.5 mL/min.  
Fractional elutions were assessed with a Coomassie Brilliant Blue R-250 (Bio-
Rad) stained 10% Bis-TRIS SDS-PAGE gel with a 1x dilution of MES running 
buffer (20x stock: 50 mM MES, 50 mM Tris Base, 0.1% SDS, 1 mM EDTA, pH 
7.3) (Invitrogen) and desired fractions were pooled and stored at 4 °C while 
concentrating. 
2.2.1.2  Concentrating WC I/II Proteins 
 Collected SEC fractions pooled and stored at 4 °C were loading into a 100 
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kDa Amicon Ultra-15 Centrifugal Filter Unit (Millipore), pre-equilibrated with 15 to 
17 mL of gel filtration buffer (GFB) at 3,000 rpm to remove trace amounts of 
glycerol applied to the filter membrane during the manufacturing process.  Once 
the membrane was readied, 15 to 17 mL of pooled protein was concentrated at 4 
°C and 2,000 rpm.  Centrifugation was stopped every 10 min to allow for 
thorough mixing.  This was continued until the volume was reduced to 
approximately 5 mL and the frequency of mixing was decreased to 5 min.  When 
the volume was reduced to approximately 2.5 to 3 mL, centrifugation was further 
reduced to 1800 rpm with mixing every 5 min.  This continued until protein was 
brought to the desired concentration as determined by Bradford assay. 
As a qualitative measure of the volume reduction, eluent was removed 
each mixing point.  As the desired concentration was approached, a sample of 
eluent was obtained for later use as a buffer standard in SAXS experiments. 
All protein and buffer samples were stored at 4 °C for SAXS experiments 
or alternatively protein needed for crystallization screening (described in Chapter 
1) was aliquoted into 50 µL aliquots and flash frozen in liquid nitrogen and stored 
at -80 °C. 
2.2.2  SEC-MALS Analysis 
A mixture of WC I (705-918) and II (174-455) was concentrated to 6.5 
mg/mL, as determined by Bradford assay, and subjected to size-exclusion 
chromatography using a WTC-030S5 column (Wyatt Technology) equilibrated in 
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150 mM NaCl, 50 mM Tris-HCl pH 8.0, 5 mM DTT, and 5 mM TCEP.  The sizing 
column was coupled to a Wyatt Technology DAWN HELEOS-II (static 18-angle 
light scattering detector) and Optilab T-rEX RI (refractive index) detector.  The 
instrument flow rate was set at 1 mL/min while the sample’s molar mass and 
mass distribution was determined with ASTRA software (Wyatt Technology).  
The samples molecular weight distribution was determined using the Multi-peak 
Fitting package in Igor Pro (WaveMetrics).  Monomeric bovine serum albumin 
(Pierce) was used as a control and to normalize the light scattering detectors. 
2.2.3  SAXS Analysis 
2.2.3.1  SAXS Data Collection on F2 Beamline 
SAXS analysis of WC proteins was performed at the Cornell High Energy 
Synchrotron Source (CHESS).  Data was collected at the F2 station through the 
use of a portable, high-throughput sample-changing system that incorporates an 
automated liquid handling system in conjunction with a quartz capillary flow cell 
[13].  The F2 station is equipped with multilayer optics that provides a 9.881 keV 
(1.256 Å) beam collimated to 250 x 250 µM.  Sample loading was facilitated by 
an automated pipetting robot that aspirates protein samples from a 96-well plate 
chilled to approximately 7°C into a quartz capillary flow cell 10 µm thick and 2 
mm in diameter.  To minimize radiation damage and subsequent deposition onto 
the capillary, samples were oscillated in the X-ray beam.  Data on the F2 station 
was collected using a PLATUS 100 K-S detector (Dectris) and calibrated using 
86 
 
the known wavelength and silver behenate powder.  Glucose isomerase and 
lysozyme (Pierce) were used as standards.  Sample loading was controlled by in-
house software (Robocon). 
2.2.3.2  Capillary Cleaning  
Prior to obtaining each sample data set, the capillary tube was iteratively 
washed with three 70 µL water plugs, followed by a 70 µL mild detergent wash 
solution consisting of 2% m/v solution of N-dodecyl-N,N-
(dimethylammino)butyrate, and again three 70 µL water plugs.  Once complete 
the capillary was washed with three 70 µL plug of 150 mM NaCl, 50 mM Tris pH 
7.5, 5% v/v glycerol, 5 mM DTT and 5 mM TCEP. 
2.2.3.3  Obtaining SAXS Buffer Scattering Profiles 
After washing the capillary with buffer, a 30 µL sample of flow-through 
collected for each protein concentration was used equilibrate the capillary and 
prevent possible dilution effects.  This was in turn followed by a second 30 µL 
plug of sample for data collection.  Each collected flow through was exposed 15 
times for 30 s, generating a set of scattering profiles that were checked for 
radiation damage and comparison to the respective sample data sets.  This 
washing process was repeated for all subsequent buffer and sample exposures. 
2.2.3.4  Obtaining SAXS Sample Scattering Profiles 
Varying dilutions of WC I and II proteins as described in Chapter 1 were 
stored for 4 to 7 h at 4 °C prior to centrifugation for 20 min at 4 °C and 14,000 
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rpm, prior to subsequent beam exposures of 15 times for 30 s.  Scattering 
profiles were regularly checked for protein aggregation, radiation damage and 
sample deposition on the capillary surface. 
2.2.3.5  Analyzing SAXS Data 
Collected data was normalized by incident intensity, averaged and plotted 
using RAW [14].  GNOM [15] was used to calculate the distance distribution 
function (P(r)), the proteins maximum dimension (Dmax) and the radius of 
gyration (Rg).  Molecular weight estimates were generated through comparison 
of scattering data to external standards [16], SAXSMOW [17] and estimates of 
the Porod volume [18]. 
DAMMIF [19] was used to generate individual molecular envelopes for 
each sample dilution, which were then averaged using DAMAVER [20] to create 
consensus envelopes.  SITUS [21] (Version 2.7.2) was used to generate bead 
models from averaged envelopes, which were fitted and visualized with Protein 
Data Bank (PDB) structures using PYMOL (Molecular Graphics System, Version 
1.3 Schrödinger, LLC) and UCSF CHIMERA (Version 1.7) [22] respectively.  
Fitting of experimental scattering curves to scattering curves generated from 
known structures was obtained using CRYSOL, Version 2.8 [23].
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2.3  Results 
2.3.1  Presentation of Sample Data 
The discussion of White Collar I and II SAXS experiments begins with N. 
crassa WC I (705-918), (705-1000) and WC II (174-455), (179-500) variants.  
Analysis for this section provides a more thorough treatment of experimental 
considerations, with subsequent sections more concisely describing the analysis 
of copurified PAS domain containing WC I/II (705-918)/(174-455) and PAS with 
the C-terminal zinc finger domain proteins (705-1000)/(179-500). 
2.3.2  WC I and II SAXS Data 
 Initial efforts to biophysically characterize N. crassa WC I and II proteins 
focused on the individual variants, whose preparation is described in Chapter 1.  
From these studies, analysis of data collected for WC I (705-1000) and WC II 
(174-455), (179-500) indicated significant aggregation in all concentrations tested 
preventing analysis (not shown).  Results for WC I (705-918), however, did not 
show significant aggregation allowing for data processing. 
2.3.3  WC I (705-918) SAXS Analysis 
2.3.3.1  Appearance of a Sharp Downturn at Small q Values in Data 
All scattering profiles obtained, including those for water, standards, buffer 
and protein samples displayed a sharp downturn at very small q values as seen 
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in the linear X-linear Y scattering profile for water (Figure 2.3.1).  This effect was 
due to placement of the beamstop at the CHESS F2 beamline and not due to 
interparticle effects, protein aggregation due to radiation damage or deposition of 
protein aggregates on the capillary tube during data collection [13].  Evaluation of 
scattering data indicated the downturn did not have an effect on subsequent data 
analysis. 
 
Figure 2.3.1  A Sharp Downturn in Scattering Data is Observed in Small q Values.  
Experimental setup at the F2 beamline resulted in a sharp downturn in very low q 
values for all collected scattering profiles as shown in a linear X–linear Y plot of the 
scattering profile for water. 
 
2.3.3.2  Evaluating WC I (705-918) for Radiation Damage 
Buffers and samples were monitored for radiation damage and 
aggregation from beam exposure by evaluating data using a variety of 
parameters.  The first method was the comparison of 15 sequential 30 s 
scattering profiles for protein concentrated to 1.2, 2.4 and 4.9 mg/mL.  I(q) versus 
q curves generated using RAW were monitored in linear X–linear Y and log X–
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log Y plots [14].  In all cases, scattering curves for each of the successive 
exposures overlapped with no shifting of q to higher or lower values, indicating 
the samples were not undergoing significant aggregation nor radiation damage 
while exposed to the beam [24, 25], as shown in log X–log Y plots (Figure 
2.3.1.1), where I(q) is the scattering intensity and q= 4πsin(θ/λ) and is defined as 
the momentum transfer [26]. 
2.3.3.3  Generating Interference-free Scattering Curves for WC I (705-918) 
To determine if the scattering data obtained for each of the WC I (705-918) 
samples had negligible interparticle effects and could represent infinitely dilute 
approximations, buffer data sets were averaged and then subtracted from 
averaged sample scattering profiles.  These curves were then plotted with linear 
X–log Y axis and scaled using RAW to generate superposition plots with linear 
X–log Y axis (Figure 2.3.1.2).  Comparison of the curves in the superposition plot 
shows scattering values at very low q values are unchanged, indicating each of 
the concentrations can be considered infinitely dilute [27].  However, the 
scattering curves do deviate at higher q values, indicative of a subtle change in 
the molecules shape, suggestive of a concentration dependent change in the 
excluded volume, which in turn can affect protein folding [26, 28]. 
2.3.3.4  Determining WC I (705-918) Rg and I(0) with Guinier Plots  
Samples were evaluated for protein aggregation and interparticle 
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Figure 2.3.1.1  WC I (705-918) Dilutions Show no Change in Scattering Profile from 
Beam Exposure.  Log X–log Y plots of 4.9, 2.4 and 1.2 mg/mL (top, middle, bottom) 
scattering profiles overlay with no change in q value, indicating protein samples did 
undergo aggregation or radiation damage from beam exposure. 
 
inference, which appear respectively as up or downturns in intensity at low q 
values, using Guinier plots [24].  For non-aggregated globular scattering 
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Figure 2.3.1.2  Superpositioned WC I (705-918) Scattering Profiles.  Averaged and 
buffer subtracted scattering profiles (top panel) show relative I(q) values for tested 
samples.  Superpositioned scattering profiles (lower panel) show good alignment at low 
q values, indicating minimal interparticle interactions in samples concentrated to 1.2, 2.4 
and 4.9 mg/mL and suggesting the samples can be considered infinitely dilute. 
 
particles, a linear dependence of log(I(q)) versus q2 up to a qRg value of 1.3 
should be observed [24].  Guinier plots generated with RAW for each WC I (705-
918) sample show a linear fit to the scattering data (Figure 2.3.1.3) with 
calculated values including Rg and I(0) listed in Table 2.3.1.   
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Table 2.3.1  Values for WC I (705-918) RAW Guinier Plots 
 
2.3.3.5  Evaluating WC I (705-918) Scattering Data with PRIMUS 
 Additional analysis of scattering data was performed with PRIMUS [29], 
which uses AUTORG [30] and GNOM [15] to obtain estimates of data quality, 
pairwise distance distribution function (P(r)), maximum distance (Dmax), Porod 
volume and Rg and I(0) estimates.  Comparison of I(0) and Rg values generated 
using the P(r) function, show good agreement with values obtained using RAW 
(Table 2.3.1.1).  P(r) functions for WC I (705-918) at 1.2 and 4.9 mg/mL (Figure 
2.3.1.4) show a smooth slope near Dmax, however the 2.4 mg/mL sample shows 
bumps near Dmax, which is indicative of protein aggregation [24, 26]. 
 Additionally, GNOM provides an estimate of data quality and indicates the 
presence of aggregation, based on the scattering data in the Guinier range.  
Quality is reported as a percentile ranging from 0 to 100% (unusable to ideal) 
and aggregation is reported as 1 (with) or 0 (without) [30].  Quality estimates 
showed a decreasing trend with values at ~80, 70 and 60% for samples 
concentrated to 1.2, 2.4 and 4.9 mg/mL respectively, with no report of 
aggregation for any of the tested samples (Table 2.3.1.1). 
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Figure 2.3.1.3  Guinier plots for WC I (705-918).  A linear fit for is obtained in the 
Guinier region for samples at 1.2, 2.4 and 4.9 mg/mL (top, middle and bottom), with no 
change in intensity at low q values, suggestive of non-aggregated samples. 
 
 2.3.3.6  WC I (705-918) Molecular Weight Estimates 
Estimates for WC I (705-918) molecular weight were generated in three 
ways, using concentration dependent and independent methods for comparison 
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Table 2.3.1.1  AUTORG and GNOM Estimates for WC I (705-918) 
 
 
 
 
 
 
 
of predicted values.  First, to obtain concentration dependent molecular weight 
estimates, I(0) values from RAW generated Guinier analysis of WC I protein 
samples, glucose isomerase (GI) and lysozyme (Lyso) standards (std) of known 
concentration were compared.  In this relationship, Mol. Wt.(sample)= 
((I(0)(sample)/c(sample)) /(I(0)(std)/c(std)))*Mol. Wt.(std), where I(0) is the forward 
scattering intensity, c is the concentration in mg/mL, Mol. Wt. is the molecular 
weight for samples and standards [16]. 
In addition to molecular weight estimates generated from the comparison 
of forward scattering data to that of known standards, mass estimates on a 
relative scale evaluating particle volume were also obtained from analysis of 
GNOM files using the online SAXSMOW server 
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Figure 2.3.1.4  P(r) Plots for WC I (705-918).  P(r) functions (right) with accompanying 
data fits (left) for samples at 1.2 and 4.9 mg/mL (top and bottom) show a smooth slope 
near Dmax, indicative of non-aggregated samples.  Small bumps near Dmax for the 2.4 
mg/mL sample (middle) suggest of the onset of aggregation. 
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(http://www.if.sc.usp.br/~saxs/saxsmow.html).  Here empirically determined 
preset qmax (Å-1) values of 0.15, 0.20 and 0.25 as provided by the SAXSMOW 
were selected for approximation of the Porod invariant (Figure 2.3.1.5) [17]. 
As a final method for comparison, molecular weight for the WC I proteins 
were estimated from Porod volumes (Vp) analysis as reported by PRIMUS, using 
an empirical relationship of (Vp*1.2)/2=  Mol. Wt. [18].  Estimates using the 
methods described show a concentration dependent increase in predicted 
molecular weight (Table 2.3.1.2 and Figure 2.3.1.6). 
Depending on a variety of experimental factors, including the accuracy in 
determining sample and standard concentrations as well as the quality of 
scattering data, molecular weight estimates obtained from SAXS experiments are 
reported to have at best an error of approximately 10% [16].  As observed in 
Table 2.3.1.2, and Figure 2.3.1.6, estimates for the WC I (705-918) samples 
show significant variation from the predicted molecular weight of a 51 kDa dimer. 
Possible explanation for the observed discrepancies in I(0) generated 
estimates can be attributed to error in the reported sample and standard 
concentrations, as this method is dependent on accurate assessment of protein 
concentration [16]. 
Estimates generated using SAXSMOW and evaluations of the Porod  
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Figure 2.3.1.5  SAXSMOW Analysis of WC I (705-918).  Analysis of Porod regions for 
1.2, 2.4 and 4.9 mg/mL (top, middle and bottom) using SAXSMOW show a low signal to 
noise ratio for qmax= 0.2 and 0.25 values, indicating the need for a qmax= 0.15 cutoff 
value in molecular weight estimations. 
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Table 2.3.1.2  Molecular Weight Estimates for WC I (705-918) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.3.1.6  A Concentration Dependent Increase in WC I (705-918) Molecular 
Weight Estimates is Observed.  Comparison of WC I molecular weight estimates from 
1) I(0) values to known concentrations of lysozyme (Lyso Std.) and glucose isomerase 
standards (GI Std.), 2) SAXSMOW estimates based on variation in qmax (qmax= 0.15, 
0.20 and 0.25) and 3) analysis of the Porod volume (Vp) as determined by PRIMUS 
using the relationship (Vp*1.2)/2=  Mol. Wt., show a concentration dependent increase 
in predicted molecular weight. 
 
volume also show deviation from the predicted molecular weight.  As seen in 
Figure 2.3.1.5, significant error is associated with scattering data at higher q 
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values for the WC I samples, limiting qmax to 0.15, and in turn making accurate 
estimation of the predicted Porod volume difficult  [17]. 
2.3.3.7  Concentration Dependent Increases in WC I (705-918) SAXS Data 
While significant aggregation was not indicated in superposition, Guinier or 
P(r) plots for WC I (705-918) scattering data, an increase in I(0), Rg, Dmax, Vp 
and molecular weight estimates with concentration is observed (Table 2.3.1.1, 
2.3.1.2 and Figure 2.3.1.7).  These increase are suggestive of either a change in 
WC I multimerization or concentration dependent aggregation in tested samples 
[26]. 
 
 
 
 
 
 
 
 
 
 
Figure 2.3.1.7  I(0) and Rg Values Show a Concentration Dependent Increases in 
WC I (705-918) Scattering Data.  Comparison of calculated Rg and I(0) values 
generated using Primus and RAW show an increase for samples at 1.2, 2.4 and 4.9 
mg/mL, which is indicative of a change in multimeric state or concentration dependent 
aggregation. 
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2.3.3.8  Evaluating WC I (705-918) Folding with Kratky Plots 
To evaluate folding and compactness of WC I (705-918), a Kratky plot 
(I(q)q2 versus q) was generated (Figure 2.3.1.8).  From this plot, a broad bell- 
  
Figure 2.3.1.8  A Kratky Plot Indicates WC I (705-918) is Folded.  Evaluation of 
scattering data shows the presence of a peak at low q and absence of a steady rise in 
I(q)q2 with increasing q, consistent with a folded protein for all proteins tested. 
 
shaped curve with no increase in I(q)q2 with q is observed for the sample at 4.9 
mg/mL, indicative of a folded globular protein with an extended conformation 
[31].  For samples at 1.2 and 2.4 mg/mL, while a lower in I(q)q2 is observed, 
neither a plateauing nor an increase in I(q)q2 with q is observed, suggesting that 
the WC I samples remain folded at lower concentrations. 
2.3.3.9  Generating WC I (705-918) ab initio Shape Reconstructions 
Low resolution three-dimensional ab initio shape reconstructions from one-
dimensional scattering data were obtained by inputting the P(r) function from 
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GNOM (output file) into DAMMIF, which incorporates a random number 
generator and a computationally intensive high temperature annealing method 
[19].  This process was repeated for each sample 10 times, with and without a P2 
symmetry constraint, resulting in shape reconstructions composed of small, 
tightly packed and interconnected dummy atoms (not shown).   
The low resolution ab initio models were then submitted to DAMAVER [20] 
for comparison and subsequent generation of a consensus envelopes.  To 
facilitate this, DAMAVER uses SUPCOMB [32] to iteratively compare and 
evaluate the models for spatial self-consistency, as defined by a dissimilarity 
measure termed the normalized spatial discrepancy (NSD).  NSD values 
between 0.4-0.7 are reported as self-consistent and well-behaved, whereas 
values ≥ 1.3 or those with a NSD greater than 2 standard deviations from the 
mean are considered poorly behaved and inconsistent. 
NSD values for each of the reconstructions were then determined by 
DAMAVER.  To facilitate this, the solutions NSD values were calculated.  The 
lowest determined NSD was then selected as a reference model and based on 
this starting point, an averaged envelope was generated.  As seen in Table 
2.3.1.3, all of the DAMMIF solutions, were considered stable and used to 
generate an averaged envelope. 
Average NSD values for consensus envelopes and their variations (ΔNSD) 
indicate solutions for each of the tested WC I (705-918) samples are well 
103 
 
Table 2.3.1.3  Statistics for WC I (705-918) ab initio DAMMIF Shape 
Reconstructions 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
behaved and self-consistent (Table 3.3.1.4), with averaged envelopes generated 
from overlapping dummy atoms of a constant sphere size as visualized using 
PYMOL (Figure 2.3.1.9).   
From these models, basic features in the envelopes with and without the 
P2 symmetry constraint are conserved.  Additionally, a subtle increase in 
envelope dimensions was observed with increasing concentration. 
Table 2.3.1.4  NSD Values for WC I (705-918) Consensus Envelopes 
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Figure 2.3.1.9  Averaged Low Resolution ab initio Shape Reconstructions for WC I 
(705-918).  Averaged consensus envelopes for 1.2, 2.4, 4.9 mg/mL (top, middle, 
bottom) show a slight increase in dimensions with increased concentration.  Also 
observed is a basic retention of symmetrical features for models with and without a P2 
symmetry constraint.
105 
 
2.3.4  Copurifying N. crassa WC I/II (705-918/174-455) 
Previously purified N. crassa WC I (705-918) and WC II (174-455) proteins 
were mixed at 0.75 and 1.5 mg/mL with equimolar concentrations and 
stoichometric ratios, for both proteins, ranging from 4:1 to 1:1 for crystallization 
screening.  In all cases protein solutions remained clear with no visible change 
upon mixing.  However, when WC I (705-1000) was mixed with WC II (179-500), 
the solution visibly precipitated at all concentrations tested, even when the buffer 
composition was identical.  This observation in concert with the uncertainty 
associated with the required ratios and concentrations needed to facilitate a WC 
I/II PAS–PAS domain interaction drove the need for another purification method. 
To address this, copurification of WC PAS domain containing proteins, I 
(705-918) and II (174-455), without the C-terminal zinc finger domains were first 
undertaken as they consistently demonstrated higher soluble protein expression 
levels and increased solution stability.  Once optimized, the method was applied 
and adapted as necessary for WC PAS domain containing proteins with the C-
terminal zinc finger domains, I (705-1000) and II (179-500). 
2.3.4.1  WC I/II (705-918/174-455) Copurification 
WC I (705-918) and WC II (174-455) proteins were expressed, harvested 
and stored separately.  Once obtained, cell pellets of approximately 12.5 g were 
resuspended in lysis buffer, mixed and the overexpressed proteins were purified 
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together, first with IMAC followed by SEC.  The principle elution peak from the 
SEC column was at 181 mL (Figure 2.3.2), and when compared to standards 
suggested a species with an apparent molecular weight of approximately 130 
kDa, larger than the predicted theoretical molecular weight of 119 kDa for WC I/II 
complex.  This elution volume of 181 mL differed substantially from previous 
purification of the individual WC I (705-918) and II (174-455) proteins, which 
eluted at 210 and 199 mL, respectively as shown in Chapter 1 (Figures 1.3.2.2 
and 1.3.2).  Analysis of SEC elution fractions with a Coomassie stained 4-12% 
SDS-PAGE gel (Figure 2.3.2) shows bands with molecular weights consistent 
with the overexpressed WC I/II proteins. 
Quantification of relative band intensity indicated an excess of WC II for 
the early portion of the primary elution peak transitioning to an excess of WC I in 
the later elution volume.  Densitometric analysis of the SDS-PAGE gels loaded 
with SEC fractions selected for concentration by Syngene GeneTools show an 
approximate excess of 20% WC II in lane 1 transitioning to an equal ratio in lane 
4 for collected fractions (Table 2.3.1.5). 
Table 2.3.1.5  Densitometric Analysis of WC I/II (705-918)/(174-455) SEC Elution 
Fractions Selected for Concentration 
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Figure 2.3.2  Copurification of WC I/II (705-918)/(174-455).  SEC elution profile of 
copurified WC I/II (705-918)/(174-455) indicates a species with a hydrodynamic radius 
consistent with the coelution of WC I/II proteins.  SDS-PAGE gel analysis of collected 
SEC elution fractions shows the presence of both proteins in the primary elution 
fractions.  Red bars on elution the profile correspond to the fractions selected for 
concentration and SAXS analysis. 
 
A consistent feature in the purification of WC I/II (705-918)/(174-455) 
proteins is formation of high molecular weight bands appearing between 60 to 75 
kDa on SDS-PAGE gels even after heating samples to 95 °C for 5 min in the 
presence of 10 mM DTT.  These bands are attributed to formation of irreversible 
protein aggregates and were minimized by maintaining a temperature of 4 °C 
during handling, frequent mixing during shortened sonication rounds, increased 
108 
 
reductant concentrations and performing SEC immediately after IMAC 
purification. 
2.3.4.2  Concentration of WC I/II (705-918)/(174-455) 
In previous concentration efforts, WC I and II SEC elution fractions readily 
produced white-precipitate in the solution with subsequent SDS-PAGE analysis 
of these samples showing high molecular weight bands.  To minimize formation 
of irreversible aggregates during concentration, SEC fractions in GFB were 
pooled and concentrated using a stepwise reduction in the centrifugation rate 
coupled with frequent mixing.  Protein samples were concentrated to 0.8, 1.7 and 
3.3 mg/mL, as determined by Bradford assay, for subsequent SAXS analysis. 
2.3.4.3  Determination of WC I/II (705-918)/(174-455) Storage Stability 
 To assess the stability of WC I/II (705-918)/(174-455) in GFB, freeze-thaw 
and storage stability studies were conducted.  For the freeze-thaw study, WC I/II 
(705-918)/(174-455) proteins concentrated to 6.5 mg/mL were aliquoted and 
flash-frozen in liquid nitrogen, then thawed on ice and evaluated using SDS-
PAGE analysis.  As shown in Figure 2.3.2.1, a single freeze-thaw cycle was 
sufficient to induce aggregation, indicating the protein should not be frozen prior 
to SAXS experiments as the scattering intensity, I(0), is proportional to square of 
the molecular weight and thus dominates the scattering signal [26]. 
Previous SDS-PAGE gel analysis of purified WC I/II stored overnight in a 
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Figure 2.3.2.1  Flash-freezing Induces Aggregation in WC I/II (705-918)/(174-455).  
SDS-PAGE gel analysis of WC I/II (705-918)/(174-455) concentrated to 6.5 mg/mL, 
before (lane 1) and after (lane 2) a freeze-thaw cycle indicate one round of freezing is 
sufficient to induce high molecular weight aggregation. 
 
variety of buffer conditions at 4 °C showed aggregate formation.  To evaluate the 
effect of short-term storage at 4 °C, samples concentrated to 6.5 mg/mL in GFB 
were taken every 4 h and monitored for aggregate formation with SDS-PAGE 
analysis.  Results indicated high molecular weight band formation was negligible 
for a period up to 12 h (not shown).  Thus, unfrozen protein was stable at 4 °C on 
the time scale needed for subsequent SAXS analysis. 
2.3.5  WC I/II (705-918)/(174-455) SAXS Analysis 
2.3.5.1  Evaluating WC I/II (705-918)/(174-455) for Radiation Damage 
To evaluate protein stability, 15 sequential 30 s scattering profiles for 
protein concentrated to 0.8, 1.7 and 3.3 mg/mL were monitored during data 
collection.  From RAW generated log X–log Y plots no shifting of q to higher or 
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lower values in (Figure 2.3.2.2), indicating the samples were not undergoing 
aggregation or radiation damage while exposed to the beam [24]. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.3.2.2  Scattering Profiles for WC I/II (705-918)/(174-455) Dilutions Show 
No Shifting from Beam Exposure.  Log X–log Y plots for WC I/II (705-918)/(174-455) 
at 3.3, 1.7 and 0.8 mg/mL (top, middle and bottom) overlay with no change in q value, 
indicating protein samples did undergo aggregation or radiation damage from beam 
exposure. 
 
2.3.5.2  Generating Interference-free Scattering Curves for WC I/II (705-
918)/(174-455) 
 
 To verify that SAXS data collected for each of the WC I/II (705-918)/(174-
455) samples had negligible interparticle effects and represented infinitely dilute 
approximations, buffer subtracted, averaged scattering profiles were first 
generated and scaled using RAW, then superposed with linear X–log Y axis 
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(Figure 2.3.2.3).  From this comparison the scattering values at low q values for 
each of the concentrations were unchanged, indicating the samples can be 
considered infinitely dilute [27].  Also observed is deviation of the 3.3 mg/mL 
 
Figure 2.3.2.3  Superpositioned WC I/II (705-918)/(174-455) Scattering Profiles 
Show No Aggregation.  Averaged and buffer subtracted WC I/II (705-918)/(174-455) 
scattering profiles show relative I(q) (top panel) and superpositioned profiles (lower 
panel) do not indicate the occurrence of interparticle interactions and samples at 0.8, 
1.7 and 3.3 mg/mL can be considered as infinitely dilute. 
 
scattering curve at higher q values, which suggests that the shape of the 
molecule is subtly changed with increasing concentration [26]. 
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2.3.5.3  Determining WC I/II (705-918)/(174-455) Rg and I(0) with Guinier 
Plots 
 
 Guinier analysis of the WC I/II (705-918)/(174-455) samples for 
aggregation or interparticle showed no up or downturns in intensity at low q 
values.  Additionally, a linear dependence of scattering data up to a qRg value of 
1.3 is observed (Figure 2.3.2.4) with calculated values including Rg and I(0) 
listed in Table 2.3.1.6. 
Table 2.3.1.6  Values for WC I/II (705-918)/(174-455) RAW Guinier Plots 
 
2.3.5.4  Evaluating WC I/II (705-918)/(174-455)Scattering Data with PRIMUS 
Additional analysis of scattering data with AUTORG [30] and GNOM [15], 
which are part of the PRIMUS [29] suite, showed good agreement with values 
obtained using RAW (Table 2.3.1.7).  Quality estimates for each of the samples 
were all reported above 70%, which is noted as good quality estimates. 
P(r) functions for each WC I/II (705-918)/(174-455) sample showed a 
smooth slope near Dmax, lacking bumps which are indicative of protein 
aggregation [24, 26] (Figure 2.3.2.5). 
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Figure 2.3.2.4  Guinier plots for WC I/II (705-918)/(174-455) Show A Linear Fit.  A 
linear fit for is obtained in the Guinier region for WC I/II (705-918)/(174-455) samples at 
0.8, 1.7 and 3.3 mg/mL (top, middle and bottom), with no change in intensity at low q 
values. 
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Table 2.3.1.7  AUTORG and GNOM Estimates for WC I/II (705-918)/(174-455) 
 
2.3.5.5  WC I/II (705-918)/(174-455) Molecular Weight Estimates 
Molecular weight estimates for WC I/II (705-918)/(174-455) were 
generated from I(0) values derived from RAW analysis of the Guinier region [16], 
the SAXSMOW online web server, which estimates mass by evaluating particle 
volumes [17] and mass estimates from evalution of the caclulated Porod volumes 
using a relationship of (Vp*1.2)/2= molecular weight [18] (Figure 2.3.2.6). 
As seen in Table 2.3.1.8 and Figure 2.3.2.7, estimates using the methods 
described showed a concentration dependent increase in predicted molecular 
weight for each sample, with significant deviation from the predicted molecular 
weight of 119 kDa. 
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Figure 2.3.2.5  P(r) Plots for WC I/II (705-918)/(174-455).  P(r) functions (with fit on 
left) for samples at 0.8, 1.7 and 3.3 mg/mL (top, middle and bottom) show a smooth 
slope near Dmax, indicative of non-aggregated samples. 
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Figure 2.3.2.6  SAXSMOW Analysis of WC I/II (705-918)/(174-455).  SAXSMOW 
analysis of Porod regions for 0.8, 1.7 and 3.3 mg/mL (top, middle and bottom) show a 
low signal to noise ratio, indicating the need for a qmax= 0.15 cutoff value in molecular 
weight estimates. 
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Table 2.3.1.8  Molecular Weight Estimates for WC I/II (705-918)/(174-455) 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
Figure 2.3.2.7  Molecular Weight Estimates for WC I/II (705-918)/(174-455) Show a 
Concentration Dependent Increase.  Comparison of WC I/II molecular weight 
estimates from 1) I(0) values to known concentrations of lysozyme (Lyso Std.) and 
glucose isomerase standards (GI Std.), 2) SAXSMOW estimates based on variation in 
qmax (qmax= 0.15, 0.20 and 0.25) and 3) analysis of the Porod volume (Vp) as 
determined by PRIMUS using the relationship (Vp*1.2)/2=  Mol. Wt., show a 
concentration dependent increase in predicted molecular weight. 
 
2.3.5.6  Concentration Dependent Increases in WC I/II (705-918)/(174-455) 
SAXS Data 
As seen in superposition, Guinier and P(r) plots of WC I/II (705-918)/(174- 
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455) scattering data, significant aggregation was not indicated.  However, an 
increase in I(0), Rg, Dmax, Vp and molecular weight estimates with 
concentration was observed (Table 2.3.1.7, 2.3.1.8 and Figure 2.3.2.8), which is 
suggestive of either a change in WC I/II multimerization or concentration 
dependent aggregation in tested samples [26].  
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.3.2.8  I(0) and Rg Values Show a Concentration Dependent Increases in 
WC I/II (705-918)/(174-455) Samples.  Comparison of calculated Rg and I(0) values 
from Primus and RAW show a concentration dependent increase for samples at 0.8, 1.7 
and 3.3 mg/mL, which is indicative of a change in multimeric state or concentration 
dependent aggregation. 
 
2.3.5.7  Evaluating WC I/II (705-918)/(174-455) Folding with Kratky Plots 
To evaluate folding and compactness, a Kratky plot of WC I/II (705-
918)/(174-455) was generated from scattering data (Figure 2.3.2.9).  From this 
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plot, each concentration tested showed a parabolic curve followed by constant 
I(q)q2 with q, indicative of a folded globular protein an extended conformation 
[31].  Also noted is a decrease in I(q)q2 at lower concentrations, however, neither 
a plateauing nor an increase in I(q)q2 with q is observed, further suggesting that 
the WC I/II samples are folded. 
 
Figure 2.3.2.9  A Kratky Plot for WC I/II (705-918)/(174-455) Shows Folded Protein.  
Evaluation of scattering data shows the presence of a peak at low q and absence of a 
steady rise in I(q)q2 with increasing q, consistent with a folded protein. 
 
2.3.5.8  Generating WC I/II (705-918)/(174-455) ab initio Shape 
Reconstructions 
Low resolution three-dimensional ab initio shape reconstructions of the WC 
I/II (705-918)/(174-455) samples, with and without a symmetry constraint, were 
obtained using DAMMIF and DAMAVER.  For DAMMIF processing, the P(r) 
function from GNOM was used to generate 10 low resolution shape constructions 
with a P1 and P2 symmetry constraint (individual models not shown) [19].  These 
models were then submitted to DAMAVER [20] and iteratively compared for 
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spatial self-consistency, resulting in subsequent generation of consensus 
envelopes. 
Results for the analysis of the models spatial self-consistency, as defined 
by a dissimilarity measure, termed the normalized special discrepancy (NSD), for 
individual envelopes and consensus envelopes is shown in Table 2.3.1.9 and 
2.3.2. 
From this analysis, all but two DAMMIF solutions for the 0.8 mg/mL 
samples, as denoted by bold values with an asterisk, were considered stable and 
used to generate an averaged envelope Table 2.3.1.9.  Reported average NSD 
values for consensus envelopes and their variations (ΔNSD) indicate solutions 
for each of the tested WC I/II (705-918)/(174-455) samples are well behaved and 
self-consistent (Table 2.3.2). 
Table 2.3.1.9  Statistics for WC I/II (705-918)/(174-455) ab initio DAMMIF Shape 
Reconstructions 
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Table 2.3.2  NSD Values for WC I/II (705-918)/(174-455) Consensus Envelopes 
 
 
Averaged envelopes with overlapping dummy atoms of a constant sphere 
size were visualized using PYMOL (Figure 2.3.3).  From these models, basic 
features in the envelopes with and without the P2 symmetry constraint are 
conserved.  Additionally, a subtle increase in envelope dimensions is observed 
with increasing concentration. 
2.3.5.9  Superposition of a Canonical PAS Structure with the WC I/II (705-
918)/(174-455) Consensus Envelope 
 
Averaged DAMAVER envelopes were further evaluated through 
superposition with a known canonical PAS fold.  To facilitate this, an internal 
fitting algorithm in UCSF CHIMERA [22] was used to create a superposition of 
the Drosophila Period structure (3RTY) with the averaged WC I/II (705-
918)/(174-455) 0.8 mg/mL envelope. 
The Period structure (229-575) is formed by two PAS AB dimers displaying 
a conical PAS–PAS repeat motif [33] that has sequence homology to the two WC 
I/II PAS domain containing proteins.  As shown in Figure 2.3.3.1, good 
agreement is observed between the mesh representation of the WC I/II (705-
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Figure 2.3.3  Averaged Low Resolution ab initio Shape Reconstructions for WC I/II 
(705-918)/(174-455).  Averaged consensus envelopes for 0.8, 1.7 and 3.3 mg/mL (top, 
middle and bottom) show a slight increase in dimensions with increased concentration.  
Also observed is a basic retention of symmetrical features for models with and without a 
P2 symmetry constraint. 
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Figure 2.3.3.1  Superposition of a Canonical PAS Structure and the WC I/II (705-
918)/(174-455) 0.8 mg/mL Envelope.  An cartoon showing the Drosophila Period PAS 
AB dimmer orientation (top left) and corresponding ribbon model (PDB: 3RTY) of two 
PAS AB dimmers (top right) used for superposition with the WC I/II (705-918)/(174-455) 
0.8 mg/mL P1 symmetry constrained consensus envelope (bottom).  From Chimera 
fitting, good agreement is observed between the low resolution envelope and the ribbon 
model, suggesting the low resolution envelope has a calculated volume sufficient to 
accommodate two WC I/II PAS dimers 
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918)/(174-455) 0.8 mg/mL envelope and two Period PAS structures, indicating 
the low resolution envelopes have a calculated volume sufficiently to 
accommodate two WC I/II PAS dimers. 
2.3.6  WC I/II (705-918)/(174-455) SEC-MALS Analysis 
To accurately determine the molecular weight of the WC I/II sample, SEC 
was used in conjunction with MALS.  The experimental setup consisted of SEC 
separation in a continuous flow experiment with a DAWN HELEOS-II and Optilab 
T-rEX (Wyatt Technology) for mass and concentration determination 
respectively.  Analysis of a sample concentrated to 6.5 mg/mL using ASTRA 
software (Wyatt Technology) and Igor Pro (WaveMetrics), indicates the presence 
of a 118 (±4%) kDa species (Figure 2.3.3.2).  The observed light scattering and 
RI signal for the tested sample displays a relative low intensity, resulting in a 4% 
error in the mass measurement.  This effect was due to sample storage for 15 
min at room temperature prior to injection, resulting in the formation of a visible 
white-precipitate, which was removed with a 13,000 rpm centrifugation at 4 °C for 
10 min.  Upon completion of centrifugation, sample concentration was not 
obtained as the sample was immediately subjected to SEC-MALS analysis. 
2.3.7  WC I/II (705-1000/179-500) – Addition of the Zinc fingers 
 Having optimized protein handling steps for WC I/II (705-918)/(174-455), 
efforts were turned to White Collar I and II proteins containing the C-terminal zinc 
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finger domains.  Results for WC I/II (705-1000) /(179-500) experiments are 
concisely presented.  For a thorough treatment of experimental SAXS 
considerations, refer to corresponding WC I (705-918) discussion. 
2.3.7.1  WC I/II (705-1000/179-500) SEC and SDS-PAGE Analysis 
Purification of WC I/II (705-1000)/(179-500) was performed with IMAC 
followed by SEC.  The principle elution peak from SEC eluted at approximately 
179 mL (Figure 2.3.3.3), suggestive of a species with an apparent molecular 
weight of approximately 131 kDa, smaller than the predicted theoretical 
molecular weight of 146 kDa for a WC I/II complex.  This elution value differs 
substantially from previous purification of individual WC I (705-1000) and WC II 
(179-500) proteins with SEC elutions of 204 and 193 mL respectively as shown 
in Chapter 1 Figures 1.3.2.3 and 1.3.1.3.  Additional analysis of the SEC profile 
indicates a small shoulder eluting near 218 kDa. 
SDS-PAGE gel analysis of SEC elution fractions (Figure 2.3.3.3) show 
minimal formation of high molecular weight bands.  Low molecular weight bands 
resulting from apparent loss of WC I was readily separable as seen in protein 
concentrated to 2.3 mg/mL.  Bands with molecular weights consistent with the 
overexpressed WC I/II are present in each of the fractions collected for 
concentration as denoted by red lines and in the concentrated protein. 
Quantification of relative band intensity with Syngene Genetools indicated
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Figure 2.3.3.2  Size Exclusion Chromatography Coupled with Multi-angle Light 
Scattering for WC I/II (705-918)/(174-455).  Static light scattering for WC I/II (705-
918)/(174-455) concentrated to 6.5 mg/mL indicates an absolute molecular weight of 
118 (±4%) kDa, closely matching the theoretical molecular weight for a WC I/II complex.  
Low light scattering and refractive index signals are due to low sample concentration 
due to poor solubility at room temperature. 
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Figure 2.3.3.3  Copurification of WC I/II (705-1000)/(179-500).  SDS-PAGE gel 
analysis of SEC elution fractions (upper left), shows protein corresponding to WC I 
(705-1000) and WC II (179-500) theoretical molecular weight.  Protein concentrated to 
2.3 mg/mL shows an absence of high and low molecular weight bands.  The SEC 
elution profile has a principle elution peak at 179 mL, suggestive of a species with a 131 
kDa apparent molecular weight, smaller than the predicted 146 kDa molecular weight 
associated with a WC I/II tetrameric complex.  Red bars on elution profile correspond to 
the SEC elution fractions selected for concentration. 
 
an excess of WC II for the early portion of the primary elution peak transitioning 
to an excess of WC I in the later elution volume.  Further, SEC fractions selected 
for concentration show an approximate excess of 20% for WC II relative to WC I 
in the concentrated protein sample (Table 2.3.2.1).
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Table 2.3.2.1  SDS-PAGE Gel Analysis of WC I/II (705-1000/179-500) SEC Fractions 
Selected for Concentration 
 
2.3.8  N. crassa WC I/II (705-1000)/(179-500) SAXS Analysis 
2.3.8.1  Evaluating WC I/II (705-1000)/(179-500) for Radiation Damage 
Buffers and samples were monitored for radiation damage by checking 15 
sequential 30 s I(q) versus q plots with linear X–linear Y and log X–log Y axis for 
shifts in q values.  As seen in Figure 2.3.3.4, curves generated using RAW 
overlap with no shift in q values, indicating the samples did not undergo 
aggregation or radiation damage while exposed to the beam [24]. 
2.3.8.2  Generating WC I/II (705-1000)/(179-500)  Interference-free Scattering 
Curves 
 
To determine if the WC I/II (705-1000)/(179-500) samples had negligible 
interparticle effects and could represent infinitely dilute approximations, samples 
were first averaged, then buffer subtracted averages of scattering data were 
generated and superpositioned with linear X–log Y axis using RAW.  From data 
analysis (Figure 2.3.3.5), no substantial change in q values is observed in the 
tested samples indicating samples can be considered infinitely dilute. 
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Figure 2.3.3.4  Scattering Profiles for WC I/II (705-1000)/(179-500) Dilutions.  Log 
X–log Y plots for WC I/II (705-1000)/(179-500) at 2.3, 1.2 and 0.7 mg/mL (top, middle, 
bottom) show no change in q value, indicating protein samples did not undergo 
aggregation or radiation damage from beam exposure. 
 
 
2.3.8.3  Determining WC I/II (705-1000)/(179-500) Rg and I(0) with Guinier 
Plots 
 Guinier analysis of scattering data was performed to evaluate data quality 
(Figure 2.3.3.6 and Table 2.3.2.2).  As seen in Guinier plots generated with 
RAW, a linear fit to the scattering data with no up or downturns in intensity at low 
q values is observed suggesting the samples are free of aggregation and 
interparticle inference. 
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Figure 2.3.3.5  Superpositioned WC I/II (705-1000)/(179-500) Scattering Profiles.  
Averaged and buffer subtracted scattering profiles show relative I(q) for tested samples 
(top panel).  Superpositioned profiles (lower panel) do not indicate the occurrence of 
interparticle interactions and samples at 0.7, 1.2 and 2.3 mg/mL can be considered as 
infinitely dilute. 
 
Table 2.3.2.2  Values for WC I/II (705-1000)/(179-500) RAW Guinier Plots 
131 
 
 
 
 
 
Figure 2.3.3.6  Guinier plots for WC I/II (705-1000)/(179-500).  A linear fit is obtained 
in the Guinier region for samples at 0.7, 1.2 and 2.3 mg/mL (top, middle and bottom), 
with no change in intensity at low q values, suggestive of non-aggregated samples. 
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2.3.8.4  Evaluating WC I/II (705-1000)/(179-500) Scattering Data with PRIMUS 
 PRIMUS was used to obtain estimates of data quality, P(r), Dmax, Porod 
volume as well as Rg and I(0) (Table 2.3.2.3).  Using the P(r) function provided 
by AUTORG, I(0) and Rg estimates were generated.  Rg values show good 
agreement with those obtained from RAW, however, I(0) values for 0.7 and 1.2 
mg/mL WC I/II (705-1000)/(179-500) differ significantly, while 2.3 mg/mL has 
good agreement (Table 2.3.2.2 and Table 2.3.2.3).  GNOM estimates of data 
quality were reported above 70% (good) and aggregation was not indicated for 
tested samples. 
 P(r) functions for WC I/II (705-1000)/(179-500) at 0.7,1.2 and 2.3 mg/mL 
(Figure 2.3.3.7) show a smooth slope near Dmax, lacking bumps which are 
indicative of protein aggregation. 
Table 2.3.2.3  AUTORG and GNOM Estimates for WC I/II (705-1000)/(179-500) 
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2.3.8.5  WC I/II (705-1000)/(179-500) Molecular Weight Estimates 
 Molecular weight estimates for WC I/II (705-1000)/(179-500) samples were 
generated from comparison of forward scattering data to that of known 
standards, SAXSMOW and analysis of the Porod volume for comparison (Table 
2.3.2.4).  As seen in Figure 2.3.3.8, SAXSMOW analysis of GNOM output shows 
significant noise due to low sample concentration, indicating the need for a 
qmax= 0.15 cutoff to minimize error in mass predictions. 
Table 2.3.2.4  Molecular Weight Estimates for WC I/II (705-1000)/(179-500) 
 
Molecular weight estimates derived from analysis of the Porod volumes as 
calculated by GNOM using a relationship of (Vp*1.2)/2= molecular weight, 
following an increasing trend with concentration similar to values obtained from 
SAXSMOW.  However, values obtained from the comparison of sample I(0) 
values to those of lysozyme and glucose isomerase indicate a sharp rise in 
molecular weight with increasing from 0.7 to 1.2 mg/mL and then a smaller 
increase to 2.3 mg/mL (Figure 2.3.3.9). 
2.3.8.6  Concentration Dependent Increases in WC I/II (705-1000)/(179-500) 
SAXS Data 
 
 While analysis of scattering data with superposition, Guinier and P(r) plots 
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Figure 2.3.3.7  P(r) Plots for WC I/II (705-1000)/(179-500).  P(r) functions (with fit on 
left) for WC I/II (705-1000)/(179-500) samples at 0.7, 1.2 and 2.3 mg/mL (top, middle 
and bottom) show a smooth slope near Dmax, indicative of non-aggregated samples.
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Figure 2.3.3.8  SAXSMOW Analysis of WC I/II (705-1000)/(179-500).  SAXSMOW 
analysis of Porod regions for 0.7, 1.2 and 2.3 mg/mL (top, middle, bottom) show a low 
signal to noise ratio, indicating the need for a qmax= 0.15 cutoff value in molecular 
weight estimates. 
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Figure 2.3.3.9  Molecular Weight Estimates for WC I/II (705-1000)/(179-500).  
Comparison of WC I molecular weight estimates from 1) I(0) values to known 
concentrations of lysozyme (Lyso Std.) and glucose isomerase standards (GI Std.), 2) 
SAXSMOW estimates based on variation in qmax (qmax= 0.15, 0.20 and 0.25) and 3) 
analysis of the Porod volume (Vp) as determined by PRIMUS using the relationship 
(Vp*1.2)/2=  Mol. Wt., show a concentration dependent increase in predicted molecular 
weight. 
 
 
did not indicate the presence of aggregation, a concentration dependent increase 
in I(0), Rg, Dmax, Vp (Table 2.3.2.2 and Table 2.3.2.3) and molecular weight 
estimates (Figure 2.3.3.9) was observed.  Comparison of Rg and I(0) values 
obtained using RAW and PRIMUS show excellent agreement between estimated 
Rg values and I(0) values (Figure 2.3.4) with both showing a concentration 
dependent increase, suggestive of either a change in multimerization or 
aggregation. 
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Figure 2.3.4  I(0) and Rg Concentration Dependent Increases in WC I/II (705-
1000)/(179-500) Samples.  Comparison of calculated Rg and I(0) values show a 
concentration dependent increase for samples at 0.7, 1.2 and 2.3 mg/mL, which is 
indicative of a change in multimeric state or concentration dependent aggregation. 
 
 
2.3.8.7  Evaluating WC I/II (705-1000)/(179-500) Folding with Kratky Plots 
 A Kratky plot of WC I/II (705-1000)/(179-500) samples was generated to 
evaluate folding and compactness (Figure 2.3.4.1).  From this plot a broad bell-
shaped curve with no increase in I(q)q2 with q is observed for sample at 2.3 
mg/mL, indicative of a folded globular protein with an extended conformation.  
Samples at 0.7 and 1.2 mg/mL show a lower I(q)q2 value, however, none of the 
concentrations tested indicate a plateauing or steady increase in I(q)q2 with q, 
suggesting the WC I/II samples are folded. 
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Figure 2.3.4.1  Kratky Plot for WC I/II (705-1000)/(179-500).  Evaluation of scattering 
data shows the presence of a peak at low q and absence of a steady rise in I(q)q2 with 
increasing q, consistent with a folded protein. 
 
 
2.3.8.8  Generation of ab initio WC I/II (705-1000)/(179-500) Shape 
Reconstructions 
For each concentration, DAMMIF was used to generate 10 low resolution 
three-dimensional ab initio shape reconstructions with and without a P2 
symmetry constraint, except for the 1.2 mg/mL sample with P1 and 2.3 mg/mL 
with P2 symmetry constraints, which had 9 and 8 models generated respectively 
(not shown).  Generated models were then evaluated using DAMAVER, which 
compared the set and determined the normalized spatial discrepancy for each of 
the low resolution reconstructions (not shown).  Once determined, DAMAVER 
selected the model with the lowest NSD as the most probable model from which 
 to generate a consensus envelope (Figure 2.3.4.2). 
Average NSD values and their variations (ΔNSD) for WC I/II (705-
1000)/(179-500) consensus envelopes indicate individual reconstructions have 
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greater spatial variation with the addition of the C-terminal zinc finger (Table 
2.3.2.5). 
Table 2.3.2.5  NSD Values for WC I/II (705-1000)/(179-500) Consensus Envelopes 
 
 
 
 
 
 
 
 
 
2.3.8.9  CRYSOL Fitting of Theoretical Mouse Period 2 Scattering Profiles to 
WC I/II Scattering Data 
 
To evaluate whether the copurified WC I/II solution complexes are a close 
representation to a crystallographically determined canonical PAS structure, the 
WC I/II scattering data was compared to the theoretical scattering profile for 
mouse Period 2 PAS AB repeat (mPER2) (PDB: 3GDI), which as seen in 
Chapter 1 (Figure 1.4.1) has high sequence homology to the putative WC I/II 
PAS AB repeat.  To facilitate this comparison, two mouse Period 2 PAS AB 
homodimers (WC I/II_tet) were arranged side by side using Xfit [34].  Also 
generated for comparison was a modified mPER2 structure, in which one of the 
WC I PAS A domains was deleted, resulting in an mPER2 PAS B/PAS AB 
structure (WC I/II_tetmod).  This change reflects the presence of the single C- 
terminally extended WC I PAS B domain (705-918) instead of the PAS AB repeat 
(586-806), as shown in Figure 1.4.1.  Finally, an octamer (WC I/II_oct) of the 
modified mPER2 PAS B/PAS AB structure was generated, as well as a 60%/40%
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Figure 2.3.4.2  Averaged Low Resolution ab initio Shape Reconstructions for WC 
I/II (705-1000)/(179-500).  Averaged consensus envelopes for 0.7, 1.2 and 2.3 mg/mL 
(top, middle and bottom) show a slight increase in dimensions with increased 
concentration.  Also observed is a basic retention of symmetrical features for the 0.7 
mg/mL models with and without a P2 symmetry constraint.  A loss of symmetry is 
observed between the P1 and P2 models for the 1.2 and 2.3 mg/mL samples. 
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 combination of modified mPER2 tetramer/octamer (WC I/II_octmod), which was 
assessed to account for possible aggregation in WC I/II scattering data. 
To compare the different mPER2 models to the WCI/II solution complex, 
CRYSOL [23] was used to generate and fit theoretical scattering curves for the 
models to the WC I/II scattering data.  As seen in Figure 2.4.1, WC I/II_tet, WC 
I/II_tetmod, WC I/II_oct, WC I/II_octmod (left panel) and WC I/II_Zntet, WC 
I/II_Zntetmod, WC I/II_Znoct, WC I/II_Znoctmod (right panel) overall show good 
agreement to both the WC I/II (705-918)/(174-455) at 0.8 and (705-1000)/(179-
500) at 0.7 mg/mL for q values (Å-1) ≤ 0.10 respectively, with the variation (χ2) 
near 1.0 for each of models. 
As aggregation is commonly seen when q values approach 0, inspection of 
the WC I/II_tet and WC I/II_tetmod fit at low q for proteins with and without the C-
terminal zinc finger (left and right panel respectively) indicate the curves have a 
larger negative log(I) values than that of the WC I/II scattering data.  With further 
assessment of the experimental fits showing WC I/II_tet has the greatest 
deviation at higher q values for both WC I/II scattering data sets.  This contrasts 
the fit of the WC I/II_oct (and WC I/II_Znoct) at small q values, which is less 
negative than the experimental data.  Finally, the fit of WC I/II_octmod (and WC 
I/II_Znoctmod) is the closet match to the experimental data, which further 
suggest the presence of aggregation in the WC I/II solution samples.
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Figure 2.3.5  CRYSOL Fitting of mouse Period 2 PAS Repeat Models to N. crassa 
WC I/II Scattering Data.  Theoretical scattering curves for mouse Period 2 PAS AB 
(WC I/II_tet), PAS B/PAS AB (WC I/II_tetmod), a linear octamer of PAS B/PAS AB (WC 
I/II_oct) and a 60%/40% combination tetramer/octamer (WC I/II_octmod) to approximate 
aggregation, as well as the corresponding models with C-terminal zinc fingers were fit to 
N. crassa WC I/II (705-918)/(174-455) at 0.8 mg/mL (left) and (705-1000)/(179-500) 
(right) scattering data at 0.7 mg/mL using CRYSOL.  In both cases, the WC I/II_octmod 
(and WC I/II_Znoctmod) theoretical curves show the best fit at very low q angles, 
suggestive of aggregation in the WC I/II scattering data. 
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2.4  Discussion 
From SDS-PAGE and SEC analysis, copurification of N. crassa WC I and 
II with and without their respective C-terminal zinc finger domains resulted in 
soluble, non-aggregated proteins.  SEC elution volumes and apparent molecular 
weights for WC I/II (705-918)/(174-455) and (705-1000)/(179-500) were distinct 
from that of the individual proteins, which as shown in Chapter 1 eluted with 
apparent molecular weights consistent with dimers.  This contrasted the primary 
SEC elution peak for both of the copurified proteins, where the hydrodynamic 
radius of approximately 130 kDa was estimated, suggestive of a WC I/II tetramer. 
These observations are further supported by the absolute molecular weight 
determination of WC I/II (705-918)/(174-455) using SEC-MALS, which indicated 
a value of 118 (±4%) kDa, consistent with the predicted molecular weight of 119 
kDa for a WC I/II (705-918)/(174-455) tetrameric complex. 
Comparison of values obtained from SAXS experiments for the individually 
purified WC I and copurified WC I/II samples further support the conclusion that a 
WC I/II PAS domain mediated tetrameric complex was formed.  As seen in 
reported values, Dmax and Rg for the individual WC I proteins were substantially 
smaller than those observed for the copurified WC I/II proteins.  An increase in 
calculated Porod volumes was also observed, as the volumes for WC I proteins 
were only 40-45% of those observed for the copurified WC I/II proteins at the 
concentrations tested. 
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Additional analysis of WC I and WC I/II SAXS scattering data, showed 
subtle shifts in larger q values in the superposition plots as well as concentration 
dependent increases in I(0), Rg and Dmax, particularly for the most concentrated 
samples.  These changes are suggestive of the onset of aggregation, which was 
also reflected as an in increase in the dimensions for the low resolution 
consensus envelopes. 
While the accurate assessment of Kratky plots was complicated by low 
scattering intensity, the plots indicate the WC proteins display globular folding 
with an extended conformation, which is also reflected in the consensus 
envelopes as they consistently showed an extended globular structure.  Another 
interesting feature estimated with the WC I (705-918) and WC I/II (705-918)/(174-
455) consensus envelopes is a conservation of symmetry for envelopes 
generated with and without a P2 symmetry constraint, while the WC (705-
1000)/(179-500) envelopes showed variations between the P1 and P2 
constraints.  One possibility for this difference could be attributed to the 
increased flexibility imparted by the proteins zinc finger domains. 
Having demonstrated the theoretical scattering profiles for the mPER2 
models closely fit the experimental WC I/II scattering data, and can be used to 
approximate the WC I/II solution complex, the WC I/II_tetmod (mPER2 tetramer), 
with and without the C-terminal zinc fingers were visualized with PYMOL.  As 
seen in Figure 2.4.1, the models reflect the elongated shape observed in the WC 
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I/II (705-918)/(174-455) and (705-1000)/(179-500) consensus envelopes.  In this 
model, the four zinc fingers, as represented by blue spheres, are aligned in a 
row. 
As the models were shown to closely fit the scattering data and match the 
basic dimensions seen in the low-resolution envelopes, this data further supports 
the formation of a tetrameric WC I/II solution complex observed in this study.  
This conclusion also suggests that N. crassa WCC is a tetrameric species, which 
is formed from interactions between the putative PAS AB repeat indicated from in 
the comparison of the WC I and II sequences to M. musculus and D. 
melanogaster PERIOD as well as M. musculus CLOCK and BMAL1 in Chapter 1. 
To evaluate possible binding of the WC I/II_tet model to separate cis-
acting proximal and distal light-acting response elements in the frq promoter 
region, first identified as conserved imperfect GATA (GATN) repeats [7, 8] and in 
later work as pseudo-palindromic repeats [9], the WC I/II_tet was aligned to a 
known structure of zinc fingers bound to DNA.  In this model, the zinc fingers are 
spaced to accommodate the distance imparted from the PAS domains.  As seen 
in Figure 2.4.2 A, the DNA bound zinc fingers (shown as blue spheres) align well 
to the PAS domains, suggesting the linear arrangement of zinc fingers in the 
tetrameric model could simultaneously bind multiple DNA sequences. 
Interestingly, the identified binding sequences in frq promoter region as 
well as an identified region for submerged protoperithecia-1 (SUB-1), a GATA 
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family transcription factor whose expression is under control of the WCC and is 
involved in fine-tuning the organisms light response, vary in the number of 
conserved binding sequences (Figure 2.4.2 B).  This suggests that oligomeric 
state of the complex might change throughout the circadian day, as the number 
of available binding sites change. 
More work will be needed to help elucidate the structure of this assembly 
and determine if the orientation of the C-terminal zinc fingers, as represented in 
Figure 2.4.1 as large blue spheres, are oriented together in the complex or are in 
a flipped orientation.  If the arrangement of the PAS domains as shown in Figure 
2.4.1 is correct and the zinc fingers are aligned when binding the four pseudo-
palindromic light response elements identified in the frequency promoter region 
(Figure 2.4.2), the complex would show similarity to the orientation of the basic 
helix-turn-helix (bHLH) domains in the mouse CLOCK:BMAL1 structure (PDB: 
4F3L), which are seen in close proximity.
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Figure 2.4.1  Orientation of PAS Domains in Mouse Period 2 PAS AB Repeat 
Model Suggest Aligned Zinc finger Domains in the N. crassa White Collar I/II 
Tetrameric Complex.  Two mouse Period 2 PAS AB dimers (PDB: 3GDI) were 
arranged to form a PAS AB tetramer using Xfit (WC I/II_tet) for comparison to the WC 
I/II scattering data and low resolution consensus envelopes.  The WC I/II_tet model 
shows conservation of the basic elongated structure as observed in N. crassa WC I/II 
(705-918)/(174-455) and (705-1000)/(179-500) envelopes. 
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Figure 2.4.2  N. crassa White Collar I/II Tetrameric PAS Complex DNA Binding 
Model.  A) Alignment of the WC I/II_tet model to a known structure of zinc fingers 
bound to DNA shows good agreement to the proposed tetrameric model.  B)  The 
identified proximal, distal and submerged protoperithecia-1 (Sub-1) pseudo-palindromic 
DNA binding sequences in the frq promoter region (red text).
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CHAPTER 3 
FUTURE DIRECTIONS 
 
3.1  Introduction 
 This section considers how additional efforts might be directed towards 
furthering our understanding of fungal circadian clock proteins, through 
development of a functional DNA binding assay, modification of purification 
conditions and design of new variants for biophysical characterization. 
3.1.1  N. crassa White Collar I and II Zinc finger DNA Binding Studies 
Preliminary experiments to demonstrate binding of White Collar (WC) I 
(705-1000), II (179-500) and copurified WC I/II (705-1000)/(179-500) zinc finger 
containing variants to rationally designed oligomers using fluoresce anisotropy 
and electrophoretic mobility shift assays with ethidium bromide visualized 2% 
agarose gels, were suggestive that binding was not occurring under conditions 
tested, as discussed in Appendix A.  To address this issue, an alternative 
approach towards the rational design of the DNA oligomers might be useful. 
The existing oligomers were designed with the thought that placing two 
conserved GATN motifs in close proximity might not only allow for DNA binding, 
but also help to order the proteins, thus facilitating their crystallization.  A 
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redesign of the oligomers based variation in the number of included pseudo-
palindromic sequence (red) for the identified proximal, distal and Sub-1 promoter 
sequences would allow for a variety of binding events (Figure 3.1).  Additionally, 
4 random bases on the 5’ side of the identified sequence could also be included, 
which could act as a linker for subsequent fluorescent labeling experiments.   
 
 
 
 
 
 
 
 
Figure 3.1  New Oligomers for DNA Binding Studies.  DNA sequences incorporating 
the identified proximal, distal and Sub-1 binding sites are presented (red). 
 
3.1.2  Experimental Variations for N. crassa White Collar II 
 Given the extensive crystallographic screening of N. crassa White Collar II 
proteins, coupled with the failure to obtain a crystal hit, additional perturbations to 
the existing approach are needed. 
 First, while significant progress was made in identifying stable WC II 
variants, relatively little success was made in the removal of the N-terminal His-
tags, which might act to sterically hinder stabilizing interactions needed for 
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crystallization.  Given the difficulty associated with tag cleavage as evidenced by 
SDS-PAGE gel analysis, expression with another affinity-tag such as small 
ubiquitin modifying protein (SUMO), which is reported to be reliably cleaved [1], 
might offer a reliable solution. 
 Another consideration is altering the buffer pH during the SEC purification 
step.  All of the preparations described in Chapter 1 used a pH close to 7.5.  The 
theoretical isoelectric point (pI) as calculated by the Scripps protein calculator: 
http://www.scripps.edu/cgi-bin/cdputnam/protcalc3 for WC II (179-500) is 
approximately 7.2 and 6.3 for each of the extended PAS only variants (174-455, 
174-449, 174-453 and 174-455).  Given this, the proteins are rendered with a 
slight negative net charge.  As observed with N. crassa WC I/II (705-918)/(174-
455) in Appendix A, significant variation in the amount of visible precipitation was 
observed in a buffer screen for proteins stored at room temperature.  Preparation 
of individual WC variants could be performed with increased pH, which might 
serve to further stabilize the proteins in solution.  Evaluation of the relative 
amount of aggregation from these screens could be monitored first visually as 
previously described, the followed by analytical SEC or with dynamic light 
scattering [2]. 
Reduction in sample aggregation would be particularly important for WC II 
(179-500), as results from small-angle X-ray scattering data (Chapter 2) indicated 
the protein was undergoing significant aggregation, thus preventing analysis.  If 
157 
 
aggregation was reduced for WC II (179-500), the program Oligomer [3] could be 
used to generate form factors, which would allow for a calculation of the ratio of 
the WC I and II proteins in a the WC I/II complex at varying concentrations. 
3.1.3  Experimental Variations for C. neoformans White Collar II 
While SDS-PAGE and SEC analysis of C. neoformans WC II PAS variants 
discussed in Chapter 1 indicated excellent stability in solution, no crystal hits 
were obtained.  To further address this issue, additional N- and C-terminal 
truncations designed to reduce variant length to the minimal PAS A core should 
be generated.  As an alternative approach to methods previously taken for the 
identification of possible truncation points of the full-length protein, analysis of 
ordered/disordered regions were generated using the IUPred [4, 5] web server.   
For IUPred analysis, an estimate of potential stabilizing inter-residue 
interactions for each amino acid in a 2-100 residues local environment were 
considered from the primary sequence.  Once the presence or absence of these 
interactions was determined, assigned energies were totaled and averaged over 
a 21 residue window.  A value of 0.5 is assigned as the cutoff between ordered 
and disorder in IUPred plots [4].  As seen in a long range disorder prediction for 
the C. neoformans WC II protein (Figure 3.2), the propensity for disorder is low 
from (41-155), which encompasses the Pfam predicted PAS domain (74-122).  
Immediately following this region, a significant spike in predicted disorder is 
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observed (155-172), with alternating values to approximately Glu262.  Given the 
difficulty in estimating the C-terminal boundaries of the PAS domain, a potential 
screen of variants based on sharp changes in the raw data (not shown) suggest 
a screen starting at Leu41 and extending C-terminally to generate (41-138, 41-
154, 41-172, 41-180, 41-214, 41-224 and 41-240). 
 
Figure 3.2  IUPRED Plot of Disorder C. neoformans White Collar II (1-392).  An 
IUPred prediction of long range (global) disorder for the full-length C. neoformans WC II 
primary sequence shows a region of low disorder (41-154), followed by a spike for 
residues (155-172).
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APPENDIX A 
SUPPLIMENTAL SECTION 
 
Appendix A 1.1  Introduction 
First addressed in the supplemental section are results from the 
purification and crystallographic screening of N. crassa Frequency (FRQ) and 
Frequency interacting RNA Helicase (FRH) variants.  This is followed by tabular 
results from individual transcriptional activator purifications, initial results from 
DNA binding experiments and supplemental N. crassa WC I/II copurification 
experiments not addressed in Chapter 2. 
Appendix A 1.1.1  Supplemental Results 
Unless otherwise noted, expression and purification conditions for variants 
discussed in the supplemental section follow methods previously described in 
Chapter 1 for N. crassa White Collar II (179-500). 
Appendix A 1.2  N. crassa Frequency 
 In an effort to further understand protein interactions in the N. crassa 
circadian clock, a short isoform of full-length FRQ (s-FRQ), which is important in 
clock temperature compensation [1], was generated for study.  Additionally, a 
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variant based on a conserved N-terminal region containing a putative coiled coil 
domain comprised of amino acid residues (145-174) [2] was also tested. 
Appendix A 1.2.1  Cloning N. crassa Frequency 
S-FRQ, which starts at codon 100 in the frq open reading frame and 
continues to the C-terminal end as well as N-terminal constructs incorporating a 
putative coiled coil domain, (99-215) were cloned by coworkers using standard 
protocols into pet28 with an N-terminal 6xHis tag (Novagen), and provided for 
overexpression in E. coli BL21 (DE3) cells (Invitrogen). 
Appendix A 1.2.2  N. crassa s-FRQ Purification and Crystallographic 
Screening 
 
s-FRQ was grown at 37 °C followed by induction at 15 °C for 15 to 26 h.  
Following harvest and storage at -80 °C, protein was purified using IMAC 
followed by SEC at 4 °C (not shown) and concentrated to 1.3, 4.8 and 7.0 
mg/mL. 
As seen in SDS-PAGE analysis of concentrated s-FRQ, significant high 
and low molecular weight banding in addition to the 97 kDa theoretical molecular 
weight expected band is observed (Figure A 1.1). 
In subsequent preparations, variation in induction temperature, addition of 
1 mM phenylmethylsulfonyl fluoride (PMSF), cOmplete, EDTA-free protease 
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Figure A 1.1  Purification of a Short N. crassa Frequency Isoform Shows 
Significant Fragmentation.  SDS-PAGE analysis of N. crassa (100-989) (s-FRQ) 
concentrated to 1.3, 4.8 and 7.0 mg/mL following IMAC and SEC purification show 
significant high and low molecular weight banding from preparations of s-FRQ isoform. 
 
inhibitor cocktail tablets (Roche) and addition of 2 mM dithiothreitol (DTT) did not 
affect stability (not shown). 
 N. crassa full-length FRQ was manually screened using Crystal Screen 1 
and 2 (Hampton Research) at 9 and 7.0 mg/mL respectively.  Protein was also 
screened using Wizard Classic 1 and 2 (Emerald BioSystems) at 5.5 mg/mL.  In 
all cases, the total drop volume was 2 µL with a 1:1 ratio of protein to well 
solution at 4 °C. 
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 Additional screening was performed using an Art Robbins Phoenix with 
protein concentrated to 1 mg/mL in 1 µL drops (1:1 ratio of protein: well solution) 
for protein stored at 4, 17 °C and RT.  All crystal screens were checked daily for 
three weeks, then weekly for approximately two months. 
Appendix A 1.2.3  Purification and Crystallographic Screening of N. crassa 
N-terminal Frequency Variants 
 
Analysis of SEC elution profile following IMAC purification of N. crassa 
FRQ (99-215) shows a principle elution peak eluting at 136 mL on a Superdex 75 
prep grade gel filtration column (GE Healthcare) (Figure A 1.1).   
 
 
 
 
 
 
 
 
 
 
 
Figure A 1.1.1  Purification of a Conserved N-terminal Region of N. crassa 
Frequency.  SEC elution profile for N. crassa FRQ (99-216) shows a primary elution 
peak at 136 mL.  SDS-PAGE analysis of protein concentrated to 15 mg/mL following 
IMAC and SEC purification shows significant enrichment with no formation of high 
molecular weight bands or low molecular weight fragmentation. 
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Selected elution fractions, as denoted by red bars, were concentrated to 
12 mg/mL and evaluated using SDS-PAGE gel analysis, which showed a 15 kDa 
band, consistent with the proteins 15 kDa theoretical molecular weight. 
N. crassa FRQ (99-215) was manually screened at 20, 10, 15, 7.5 and 5 
mg/L using Crystal Screen 1 and 2, Wizard Classic 1 and 2, PEG/Ion Screen 1 
and 2 using a ratio of 1 µL protein to 1 µL well condition in hanging drops at RT.  
Crystal screens were checked daily for 1 month, then weekly for 3 months.  The 
majority of well conditions (approximately 80%) from these screens was clear or 
had very light precipitation. 
Appendix A 1.3  Cloning N. crassa Frequency 
N. crassa FRH (114-1026) was cloned by coworkers using standard 
protocols into pet28 with an N-terminal 6xHis tag (Novagen), and provided for 
overexpression in E. coli BL21 (DE3) cells (Invitrogen). 
Appendix A 1.3.1  Purification and Crystallographic Screening of N. crassa 
FRH 
 
 A 25 gram preparation of N. crassa FRH (114-1026) based on sequence 
homology to the structurally determined Saccharomyces cerevisiae RNA 
helicase Mtr4 (PDB: 3L9O) [3, 4] was grown at 37 °C for 3 h, followed by 
induction at 14 °C for approximately 20 h.  Harvested protein was purified first 
using IMAC followed by SEC.  As seen in SDS-PAGE analysis of protein 
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concentrated to 13 mg/mL (Figure A 1.2), a band consistent with the proteins 113 
kDa molecular weight is observed.  Also noted is minimal formation of high and 
low molecular weight bands indicative of protein aggregation and fragmentation 
respectively. 
 Concentrated protein was manually screened at 13 mg/L using Crystal 
Screen 1 and 2 and Wizard Classic 1 and 2 in 2 µL drops (1 µL protein:1 µL well 
condition) in hanging drops at 17 C.  Crystal screens were checked daily for 3 
weeks.  Results from the screen indicated an equal distribution of clear to light, 
medium and heavy precipitated drops. 
Appendix A 1.4  Experimental Notes for WC II and Related Homologs 
Purified in Chapter 2 
 
Supplemental details and experimental results from the purification WC II 
homolog variants discussed in Chapter 1 are presented in Table A 1.  Briefly, a 
qualitative estimate of the maximum total soluble protein (TSP) obtained for each 
variant, as determined by the Bradford assay of concentrated protein from IMAC 
capture followed by SEC purification is listed.  Reported TSP values do not 
reflect target protein band in SDS-PAGE gel analysis and thus include impurities, 
aggregates and fragmentation products.  Supplemental notes are provided for 
variants that readily precipitated during purification steps and appeared to have 
with the apparent molecular weight expected for a monomer). 
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Figure A 1.2  SDS-PAGE Analysis of Purified Neurospora crassa Frequency 
Interacting RNA Helicase (FRH).  SEC elution profile for N. crassa FRH (114-1026) 
shows a primary elution peak at 136 mL.  SDS-PAGE analysis of protein concentrated 
to 13 mg/mL following IMAC and SEC purification shows significant enrichment with no 
observed formation of high molecular weight bands and minimal protein fragmentation. 
 
successful cleavage of the His-tag as determined by target band shifts in SDS-
PAGE analysis. 
 Also noted is the mM concentration of NaCl and Tris buffer in gel filtration 
buffer conditions (when varied).  Finally a qualitative assessment of the SEC 
elution profile is provided with loss of an apparent dimer noted as either 
multimeric (multiple elution peaks) or monomeric (single elution value consistent 
167 
 
Table A 1  Summary of Experimental Notes for N. crassa WC II and Related 
Homologs Discussed in Chapter 1. 
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Appendix A 1.5  Results from Preliminary N. crassa White Collar II (179-500) 
DNA Binding Experiments 
 
 Efforts to develop a functional DNA binding assay for recombinantly 
expressed White Collar I and II transcriptional activators, containing the proteins 
C-terminal Zinc-finger, were based on a conserved imperfect GATA repeat 
(GATN) essential for induction of FRQ gene product as identified in deletion 
studies of proximal and distal regions in the frq promoter [5].  Also observed in 
this study, was identification of a three base-pair linker between the conserved 
GATN repeats from alignment of promoter region to another N. crassa light-
induced clock gene product (albino-3). 
 From this work, rationally designed single-stranded DNA oligomers and 
their complimentary antisense sequences were generated and annealed using 
standard protocols, for use in both DNA binding assays and crystallographic 
screening.  For crystallographic screening, design of the DNA oligomers focused 
on inclusion of the imperfect GATN repeat, where N can be any base, but must 
be the same in the repeat [5] (Figure 1.3).  Further, observation that N. crassa 
WC II (179-500) appeared to elute as a dimer in SEC purifications drove the idea 
that two GATN repeats, either with (to potentially accommodate for steric 
hindrance during binding) or without separation by the identified albino-3 linker, 
would allow for simultaneous binding of both Zinc-fingers in the putative White 
Collar dimer, which might help in inducing order in crystallographic screening 
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experiments.  Details for crystallographic screening with the DNA oligomer were 
detailed in Chapter 1. 
 
 
 
Figure A 1.3  Rationally Designed DNA Oligomer for N. crassa White Collar 
Crystallographic and DNA Binding Experiments.  Generation of a rationally 
designed single-stranded DNA oligomer for crystallographic screening included an 
imperfect GATA repeat (GATN), where N was selected as cytosine (black), separated 
with a three base-pair linker identified in the albino-3 coding region (green).  An 
additional four base-pair linker (orange) was added to the  on the 3’ and 5’ end of the 
sequence to facilitate linkage to a 5’ Cy5 fluorescent label for use in fluorescent 
anisotropy experiments to assess White Collar DNA binding.  Prior to use in 
crystallographic experiments the sense strand (top sequence) was annealed to the 
complimentary anti-sense strand (bottom sequence). 
 
 As a first approach in probing this interaction, a Cy5 fluorescent dye was 
added to the 5' end of the sense strand for use in fluorescence anisotropy 
experiments.  The choice of Cy5 as a fluorescent reporter was determined by 
limitations in the range of measureable excitation/emission wavelengths in the 
experimental setup.  Also considered was the possible steric hindrance of Cy5 on 
Zinc-finger/GATN binding.  To address this issue a four-base pair linker was 
added in the sequence (Figure 1.3). 
Subsequent fluorescent anisotropy experiments based on the µL titration 
of 143 µM N. crassa WC II (179-500 to a 25 nM Cy5 solution resulting in a final 
concentration ranging from 75 nM to 2.5 µM, failed to show changes in 
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fluorescence anisotropy.  This result suggests that a binding event did not occur 
in the tested conditions (not shown). 
 As a second approach to investigating possible DNA binding, 
electrophoretic mobility shift experiments with ethidium bromide visualized 2% 
agarose gels was conducted following standard protocols.  Briefly, 5 µL of N. 
crassa WC II (179-500), WC I (705-1000) and copurified WC I/II (705-1000)/(179-
500) each at 6 µM, were mixed in 1:5, 2:5 and 5:1 ratios (protein:DNA) with the 
oligomers lacking the Cy5 label at 25 mM and allowed to incubate at 4 °C for 20-
30 min.  The mixtures were then loaded into a prechilled 2% agarose gel and run 
at 100 V for 30 min.  Once complete, ethidium bromide was added and the gels 
were incubated with rocking for 30 min at room temperature (no EDTA was 
present in the gel or buffer).  Results from these experiments clearly showed 
migration of the DNA in the gel with no shift observed for samples containing the 
protein relative to standards lacking the protein, suggestive that binding did not 
occur in tested conditions (not shown). 
Appendix A 1.6  Supplemental N. crassa WC I/II Copurification Experiments 
Based on observations from the copurification of N. crassa White Collar I/II 
proteins as described in Chapter 2, additional variants were generated for 
additional studies.  Results presented reflect single preparations using conditions 
identified for N. crassa WC I/II (179-500)/(705-1000). 
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Appendix A 1.6.1  SEC-MALS Analysis of N. crassa WC I/II (174-455)/(705-
918) in a High Ionic Strength/pH Buffer 
 
 As described in Chapter 2, low protein solubility at room temperature 
resulted in precipitation prior to SEC-MALS injection and thus, low signal 
intensity in the scattering experiment.  To address this, copurified protein was 
screened against various buffers using Salt RX 1 and 2 (Hampton Research) at 
6.5 mg/mL (GFB: 150 mM NaCl, 50 mM Tris buffer, pH 7.5, 5 mM DTT and 5 mM 
TCEP) in 2 µL total drop volumes (1 µL protein:1 µL well solution).  Protein was 
stored at room temperature and monitored for visible precipitation after 8, 12, 24, 
36 and 48 h.  From this screen, NaCl was identified as having minimal visible 
precipitation upon inspection with a light microscope.  Using the same method, 
the protein was rescreened against NaCl concentrations ranging from 50 to 950 
mM in 50 mM increments.  Results from this screen suggested reduced visible 
precipitation in concentrations at and above 300 mM NaCl.  As a final variation, 
the protein was again rescreened in GFB containing 300 mM NaCl, 50 mM Tris 
buffer, pH 7.5, 5 mM DTT and 5 mM TCEP against a pH screen from 2 to 11 in 
0.5 increments using a variety of buffers.  From these results, drops at and above 
pH 9.0 did not display visible precipitation at room temperature even after 3 days. 
 With these results in mind, a 25 gram preparation of N. crassa WC I/II 
(174-455)/(705-918) was subjected to IMAC and SEC purification.  As seen in 
Figure A 1.3.1, the SEC elution profile using a GFB containing 300 mM NaCl, 50 
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Figure A 1.3.1  N. crassa WC I/II (174-455)/(705-918) Shows a Decreased 
Hydrodynamic Radius at pH 9.0.  The SEC elution profile for N. crassa WC I/II (174-
455)/(705-918) shows a primary elution peak at 185 mL, suggestive of a 112 kDa 
species.  SDS-PAGE analysis of SEC elution fractions show bands corresponding to 
the WCI and II theoretical molecular weight, with minimal protein fragmentation. 
 
mM HEPES, pH 9.0, 5 mM DTT and 5 mM TCEP showed a principle elution 
peak at 185 mL, which when compared to known standards suggested a species 
with a 112 kDa molecular weight, small than the proteins 118 kDa theoretical 
molecular weight.  This value is also smaller than the 130 kDa observed 
previously using a 150 mM NaCl and Tris buffer pH 7.5 buffer, suggestive of a 
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small hydrodynamic radius for the complex.  SDS-PAGE gel analysis of SEC 
elution fractions indicated the presence of high molecular weight bands, which 
are suggestive of irreversible protein aggregation.  From analysis of the 
preparation it is unclear if the increased high molecular weight banding is due to 
protein handling or reduced stability in the buffer. 
 Following SEC purification, selected fractions, as denoted by red bars on 
the SEC elution profile and accompanying SDS-PAGE gel were concentrated to 
7.5 mg/mL and stored at 4 °C for SEC-MALS analysis using the same 
experimental procedure described in Chapter 2 methods section.  
Prior to injection, the concentrated protein was stored at room temp and 
did no visibly precipitate prior to injection.  Following injection, SEC-MALS 
analysis (Figure A 1.3.2) indicated a species with a 103 kDa (±2%) molecular 
weight, smaller than the theoretical molecular weight for a WC I/II complex, as 
well as the 118 kDa value from the previous SEC-MALS analysis (Figure 
2.3.3.2). 
Further observed is a decrease in molecular weight for the complex during 
protein elution, possibly suggestive of dissociation of the complex during the 
experiment, which was not observed in the previous SEC-MALS experiment. 
Finally, noted was the observation that the protein appeared to interact 
with the column during the experiment, as evidenced by a low scattering and
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Figure A 1.3.2  N. crassa WC I/II (174-455)/(705-918) SEC-MALS Analysis.  SEC-
MALS analysis of copurified of N. crassa WC I/II (174-455)/(705-918) in 300 mM NaCl 
and HEPES pH 9.0, resulted in a 103 (±2%) kDa complex.  This value is smaller than 
the complexes theoretical 118 kDa molecular weight. 
 
refractive index signal persistent (not shown). 
Appendix A 1.6.2  Copurification of N. crassa WC I (705-918)/VVD  
 As described in Chapter 2, an 37 amino acid N-terminally truncated variant 
of N. crassa Vivid (VVD) was copurified with N. crassa WC I (705-918) using 
conditions previously described in Chapter 2 for N. crassa WC I/II (174-
455)/(705-918).  
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SDS-PAGE analysis of SEC elution fractions from a 25 g preparation 
(Figure A 1.3.3) failed to show coelution of the two proteins principle elution 
peaks, suggesting a lower affinity between the proteins in the current buffer 
composition. 
SEC elutions values for the WC I (705-918) and VVD were consistent with 
those previously observed using a HiLoad 26/60 Superdex 75 prep grade gel 
filtration column (GE Healthcare) equilibrated with 150 mM NaCl, 50 mM Tris pH 
7.5, 10% v/v glycerol, 5 mM DTT and 5 mM TCEP (not shown). 
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Figure A 1.3.3  Copurification of N. crassa WC I (705-918) and Vivid Did Not Show 
Coelution in SEC Purification.  SDS-PAGE gel analysis and SEC elution fractions of 
co-purified N. crassa WC I (705-918)/VVD, does not shown co-elution in SEC 
purification, indicating a weak nor non-existent interaction for the two proteins in tested 
buffer conditions. 
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